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One of the earliest responses to DNA double strand breaks is phosphorylation of 
the C-terminal tail of histone variant H2A.X at position S139. The phosphorylated 
form (γH2A.X) is a marker of DNA damage and promotes DNA damage repair 
(DDR). Recent work showed that H2A.X can also be phosphorylated at position 
Y142, and that increasing Y142 phosphorylation by siRNA knockdown of the Eyes 
Absent (Eya) phosphotyrosine phosphatases (which remove Y142 phosphates) 
leads to increased apoptosis in response to DNA damage. This led to the proposal 
that an epigenetic “switch” between mono-γH2A.X (S139 only phosphorylated) and 
di-γH2A.X (S139 and Y142 both phosphorylated) directs the choice between DNA 
repair vs apoptosis in response to DNA damage. In this study, we sought to test 
this “switch” hypothesis by testing for cooperativity between the DNA damaging 
drug, Bleomycin, and Benzbromarone – a pharmacological inhibitor of Eya 
phosphatases. Although little cooperativity between Bleomycin and 
Benzbromarone was found in cell proliferation assays, live-cell imaging with 
fluorescent markers of apoptosis showed an increase in cell death. Moreover, by 
using novel antibodies that specifically recognise the various phosphorylated forms 
of H2A.X, immunochemical staining revealed that di-γH2A.X is located adjacent to 
and “flanks” γH2A.X in DDR foci, and is interspersed with γH2A.X in apoptotic 
cells. Therefore, contrary to the “switch” hypothesis being the singular function of 
di-γH2A.X, these results suggest an additional model for the role of di-γH2A.X in 
DDR, in that it may also act as a limiting factor in the rate of expansion of γH2A.X 
repair foci. 






1.1 Histones and H2A.X 
1.1.1 Chromatin structure and function 
To facilitate the accommodation of !2m of DNA inside the !10µm nucleus of a 
human cell, the genome is tightly compacted into the highly conserved chromatin 
structure (Kinner et al., 2008). The basic unit of chromatin is the nucleosome, 
consisting of a !100 kDa octamer of highly basic histone proteins, around which 
147 bps of the DNA double helix is wrapped in a left-handed superhelical turn 
(~1.7 times) (Bao, 2011).  
 
The histone octamer is comprised of two copies each of four, small core histone 
proteins: H2A, H2B, H3, H4, and a linker histone protein, H1. Core histones H2A 
and H2B associate as a dimer and histones H3 and H4 associate as a tetramer; 
one H3-H4 tetramer then associates with two H2A-H2B dimers to form the 
complete octamer (Luger, Dechassa and Tremethick, 2012).  
 
In the primary chromatin structure, nucleosomes are separated by short linker-DNA 
segments (20-80 bps); termed the ‘beads-on-a-string’ organisation, chromatin then 
undergo higher levels of condensation to form the secondary chromatin structure 
(a 30nm fibre), mediated by interaction between N-terminal domains of adjacent 
nucleosomes, as well as through non-histone proteins (Luger, Dechassa and 
Tremethick, 2012).  





Higher order tertiary structures are then formed through fibre-fibre interactions and 
stabilised by histone H1, as well as architectural proteins such as heterochromatin 
protein 1 (HP1), poly (ADP-ribose) polymerase 1 (PARP1), and methyl-CpG-













The chromatin structure allows not only the compaction of DNA, but also regulates 
the accessibility to the genome during transcription, replication, and repair. This 
structure can be dynamically altered to facilitate or repress the access to DNA, 
enabled by mechanisms such as ATP-dependent chromatin remodelling 
complexes, histone variant incorporation, and histone covalent modifications (Bao, 
2011); chromatin remodelling complexes can also remove or exchange 
nucleosomes (Hargreaves and Crabtree, 2011). 
Figure 1-1 Structure of chromatin 
Nucleosomes form the primary structure of chromatin, known as the ‘beads-on-a-string’ 
organisation. Interactions between adjacent nucleosomes leads to higher levels of condensation, 
forming a 30nm fibre (secondary structure). Fibre-fibre interactions and stabilisation by scaffold 
proteins leads to the highly condensed, tertiary chromatin structure (Luger, Dechassa and 
Tremethick, 2012). 
 





1.1.2 Histone variants 
The substitution of core histones with histone variants at specific sites can 
generate a functionally and architecturally distinct chromatin structure. The histone 
variants are highly conserved between species, indicating that they have specific 
functions that the canonical histones cannot fulfil (Luger, Dechassa and 
Tremethick, 2012).  
 
Their expression is replication independent and therefore, unlike the expression of 
canonical histones that are encoded by replication-coupled genes, histone variants 
are not restricted to the S-phase of the cell cycle (Henikoff, Furuyama and Ahmad, 
2004). Histone variant incorporation often involves ATP-dependent chromatin 
remodelling factors and specific histone chaperones; an example of which is the 
exchange of H2A with H2A.Z at specific chromosome locations, facilitated by the 
ATP-dependent SWR1 complex (Mizuguchi et al., 2004). H2A.Z has also been 
found to be incorporated near silenced regions of the genome, inhibiting the spread 
of silent heterochromatin (Meneghini, Wu and Madhani, 2003).  
 
1.1.3 Post-translational modifications of histones 
The flexible histone tails extend away from the nucleosomal DNA and are the sites 
at which many post-translational modifications to amino acid side chains occur, 
facilitated by several families of catalytic enzymes (Chen et al., 2013).  
 





These modifications include phosphorylation, methylation, acetylation, biotinylation, 
ubiquitylation, SUMOylation, and ADP-ribosylation; they serve to alter electrostatic 
interactions between DNA and histones, facilitating the accessibility of cellular 
functions and changing the dynamics of chromatin (Hunt et al., 2013).  
 
Many of these modifications occur constitutively in undamaged regions of 
DNA/chromatin and several studies have found that some of these pre-existing 
modifications have important roles in facilitating the recruitment of DNA damage 
repair proteins during the DNA damage response (DDR). This includes the finding 
that either the methylation of histone H3 at lysine-79 (H3K79) or the di-methylation 
of histone H4 at lysine-20 (H4K20me2) is required for focus formation of the DNA 
repair protein, p53-binding protein 1 (53BP1) (Huyen et al., 2004; Botuyan et al., 
2006). Furthermore, it has been found that post-translational modification of 
histones in regions of transcriptionally active genes is coupled to preferential DNA 
double strand break repair (Chaurasia et al., 2012). 
 
One of the best characterised post-translational modifications that occurs in 
response to DSBs is the phosphorylation of serine-139 (S139) on the C-terminal of 
histone variant H2A.X, referred to as γH2A.X (Pilch et al., 2003). In addition, it has 
been found that phosphorylation of the N-terminal of H4 at serine-1 (Cheung et al., 
2005), and H2B at serine-14 (Fernandez-Capetillo, Allis and Nussenzweig, 2004), 
also occur in the DDR. 
 






H2A.X is one of the most conserved variants of H2A; it differs from H2A in that it 
has an extended C-terminal tail (an additional 14 amino acids), on which there is 
an SQEY motif. The primary sequence of H2A.X is different from H2A in just four 
amino acids: Q6T, T16S, N38H and K99G (Bonisch and Hake, 2012). It is 
ubiquitously expressed in all cell types and represents between 2-25% of the H2A 














Since the discovery that exposure to ionising radiation results in γH2A.X formation, 
as part of the DDR (Rogakou et al., 1998), it has been the subject of many 
subsequent studies.  
Figure 1-2 Structure of histone H2A.X and model of the nucleosome core 
H2A.X has a characteristic H2A domain, which ranges from 18-91 amino acids (aa) that contains 
the 22-28aa H2A signature motif. H2A.X differs from H2A in that it has an extended C-terminus 
containing the SQEY-motif (residues 140-143) (left). A schematic drawing (right) of the DNA 
interaction with the histone octamer and histone tails, including that of histone variant, H2A.X 
(H2AFX (H2A histone family, member X);  Kinner et al., 2008). 
 





A more recent comprehensive screen of H2A.X residues revealed that in addition 
to phosphorylation, H2A.X is also modified by acetylation, ubiquitylation, and 
SUMOylation (Chen et al., 2013; van Attikum and Gasser, 2009).   
 
In addition to its more characterised role in the DDR, H2A.X performs a multitude 
of biological processes, including roles in sex chromosome inactivation in germ 
cells, X chromosome inactivation in somatic cells, chromatin regulation in mitosis, 
embryonic stem cell development, neural stem cell development, asymmetric sister 
chromosome segregation, and cellular senescence maintenance (Turinetto and 
Giachino, 2015). 
 
1.2 H2A.X in the DNA Damage Response 
1.2.1 DNA damage 
Cells are constantly exposed to endogenous and exogenous stresses that induce a 
multitude of DNA lesions, of which many thousands arise every day in mammalian 
cells (Polo and Jackson, 2011). Endogenous stresses come from essential 
metabolic activity, such as oxidative respiration and lipid peroxidation that generate 
reactive oxygen species (ROS); exogenous stresses come from numerous 
environmental agents such as ionising radiation (IR) and ultraviolet (UV) light, as 
well as genotoxic chemicals that are present in combustion products and food 
(Dinant, Houtsmuller and Vermeulen, 2008; Iliakis, Murmann and Soni, 2015).  
 





These potentially harmful DNA lesions include double strand breaks (DSBs), which 
can also occur as intermediates during meiotic and V(D)J recombination (Khanna 
and Jackson, 2001), and have to be efficiently repaired in order to prevent genetic 
rearrangements that can lead to genomic instability, cell death or oncogenic 
transformation.  
 
1.2.2 Repair of DNA damage 
Erroneous DNA repair can lead to chromosomal aberrations, therefore eukaryotic 
cells have evolved an elaborate system for DNA damage detection to prevent the 
transmission of this genetic instability to their offspring; this involves regulating 
access to the site of damage through chromatin structure alterations, the 
coordination with cell-cycle checkpoints, and arrest of cell-cycle progression 
(Torgovnick and Schumacher, 2015). DNA damage therefore initiates a complex 
cascade of cell signalling, chromatin modification, and repair events. 
 
DSBs are among the most toxic of DNA lesions and can be induced by IR in all 
phases of the cell cycle. The repair of these is therefore critical as incorrect repair 
of such lesions can lead to chromosomal translocations; whereas left unrepaired, 
these lesions can result in cells undergoing apoptosis or senescence, or the loss of 
chromosome fragments causing the potential loss of essential tumour suppressor 
genes (Davis and Chen, 2013; van Gent and Kanaar, 2016).  
 





There are at least four major pathways that have evolved to deal with the many 
different types of DNA lesions that occur: base excision repair (BER), nucleotide 
excision repair (NER), non-homologous end joining (NHEJ), and homologous 
recombination (HR). Small, non-helix distorting base lesions are excised and 
replaced by BER (Caldecott, 2007; Kim and Wilson, 2012); whereas NER is able to 
target may different types of single-strand breaks that destabilise the structure of 
the double helix, including the cyclobutene pyrimidine dimers and 6-4 
photoproducts induced by UV, as well as large or bulky chemical adducts (Schärer, 
2013).  
 
The more harmful lesions caused by DSBs are dealt with by HR and NHEJ 
(Dinant, Houtsmuller and Vermeulen, 2008): HR utilises the presence of a 
homologous template, usually a sister chromatid, to make an accurate repair and 
this method is therefore predominantly post-replicative in the S- and G2-phase of 
the cell-cycle (Li and Heyer, 2008); whereas whilst NHEJ can also target DSBs in 
S-phase, this is a more error prone repair mechanism that operates mainly in G1-
phase and utilises the Ku heterodimer (Ku70 and Ku80 proteins) to directly ligate 
DNA ends, with minimal processing (Davis and Chen, 2013).  
 
1.2.3 Role of γH2A.X in the DNA Damage Response  
During the process of sensing DNA damage and subsequent repair, histones 
undergo post-translational modifications to be able to direct the recruitment of DNA 
repair proteins. These modifications include phosphorylation, ubiquitylation, 





methylation, and acetylation; these also serve to assist the restoration of chromatin 
to its native state following repair (van Attikum and Gasser, 2009; Hunt et al., 2013; 
Chen et al., 2013). In response to DSBs, H2A.X is phosphorylated on its carboxy-
terminal tail, at S139, by phosphatidylinositol 3-kinase-related kinases (PIKKs) 
such as ataxia telangiectasia-mutated (ATM), ataxia telangiectasia and Rad3-
related protein (ATR), and DNA-dependent protein kinase (DNA-PK), to form long 
stretches of γH2A.X that flanks the DSBs; this occurs within minutes following 
exposure to IR (Pilch et al., 2003; Cook et al., 2009; Zhu et al., 2011). γH2A.X 
forms a domain that extends up to 50 kilobases either side of the DNA damage in 
yeast (Shroff et al., 2004), and several mega-bases in mammals (Rogakou et al., 
1999). This leads to the recruitment of DNA damage repair proteins such as the 
mediator of DNA damage checkpoint protein 1 (MDC1), p53-binding protein 1 
(53BP1), the breast cancer type-1 susceptibility protein (BRCA1), and the MRE11–
RAD50–NBS1 (MRN) complex (van Attikum and Gasser, 2009). 
 
In addition, the formation of γH2A.X also facilitates the recruitment of chromatin 
remodelling complexes, such as RSC and SW1/SNF (Park et al., 2006), as well as 
other repair proteins belonging to the SWI2/SNF2 family of dsDNA-dependent 
ATPase helicases that are involved in the DDR, such as RAD5, RAD16, RAD54 
and CSB/RAD26 (Ceballos and Heyer, 2011; Ortiz-Bazán et al., 2014); thus H2A.X 
is a central player in the DDR and therefore deficiency is linked to decreased 
genomic stability and an increased susceptibility to tumour development in normal 
cells and tissues (Zhu et al., 2011).  





The finding that the MRN complex protein, NBS1, binds to and activates the ATM 
kinase provides a model for how MDC1 is able to extend phosphorylation of H2A.X 
over large regions of chromatin (van Attikum and Gasser, 2009). Specifically, the 
MRN complex recognises and binds to DSBs (Petrini and Stracker, 2003), this then 
recruits ATM through an interaction with the C-terminus of NBS1 (You et al., 2005). 
This recruitment of ATM leads to phosphorylation of H2A.X (Burma et al., 2001) 
and subsequent recruitment of MDC1. This in turn promotes the recruitment and 
retention of further MRN complex proteins, promoted by the phosphorylation of 
MDC1 by casein kinase 2 (CK2) (Spycher et al., 2008); thus more ATM is recruited 
through interaction with NBS1 and provides a positive feedback mechanism which 
allows the extension of γH2A.X to surrounding chromatin (Figure 1-3). This signal 
amplification allows for transmission of a localised DNA repair process to activation 








Figure 1-3 Initiation of repair foci in the DNA Damage Response 
(a) Induction of DSB (b) The MRN complex binds to the ends of DSBs and recruits ATM. ATM 
phosphorylates H2A.X, leading to recruitment of MDC1. MDC1 recruits further MRN complexes, 
and in turn further ATM. ATM phosphorylates proximal H2A.X, allowing spread of γH2A.X to 
surrounding chromatin. TIP60 acetylates γH2A.X which initiates γH2A.X polyubiquitylation by 
UBC13 for γH2A.X removal (adapted from van Attikum and Gasser, 2009). 







Programmed cell death is an evolutionary conserved process that has distinct 
morphological characteristics (Kerr, Wyllie and Currie, 1972). It plays an important 
role in both the development of multicellular organisms, such as tissue sculpting in 
embryonic development; maintenance of tissue homeostasis by the elimination of 
cells in normal turnover as well as those that are potential harmful; and through 
chemically induced cell death (Elmore, 2007; Nagata, 2010). The deregulation of 
apoptosis therefore has implications in many diseases, including autoimmune 
disease and cancer (Solier and Pommier, 2014).  
 
Apoptosis can be triggered by various stimuli, including endoplasmic reticulum 
(ER) stress, oxidative stress, irradiation, and chemotherapeutic agents (Ichim and 
Tait, 2016). There are two distinct pathways that initiate the first stage of apoptosis, 
cell death: extrinsic apoptosis is initiated by the death receptor mediated pathway, 
by ligands such as tumour necrosis factor (TNF) and TNF-related apoptosis-
inducing ligand (TRAIL) at the cell surface; whereas intrinsic apoptosis is initiated 
by the mitochondrial pathway (Murphy, Perry and Lawler, 2008).  
 
Caspases are a family of aspartate-specific cysteine proteases that are 
synthesised as inactive proenzymes. These act as death effector molecules upon 
activation, causing a sequential activation of downstream caspase zymogens 
(Taylor, Cullen and Martin, 2008).  During the extrinsic apoptotic pathway, the 





ligand binding initiates the recruitment of adapter proteins and molecules of the 
initiator caspases (procaspase-8 and -10) to the cytosolic face of the death 
receptor (Zhao, Sui and Ren, 2010). Cleaved, activated initiator caspases then 
propagate the signal through proteolytic activation of downstream executioner 
caspases: caspase -3, -6 and -7 (Wachmann et al., 2010). 
 
A dynamic equilibrium exists in the BCL-2 family members, which consist of pro- 
and anti-apoptotic proteins; these play key roles in the mitochondrial-mediated 
apoptotic pathway which can arise from a number of stimuli, including DNA 
damage (Ichim and Tait, 2016). Pro-apoptotic proteins translocate to the 
mitochondria where they negate the protective activity of anti-apoptotic proteins, 
thereby causing membrane permeabilisation and an efflux of pro-apoptotic proteins 
such as cytochrome c into the cytosol (Nagata, 2010). Cytochrome c then binds to 
apoptotic protease-activating factor 1 (APAF-1) and together with the initiator 
caspase-9 forms the apoptosome, which leads to activation of the executioner 
caspases -3, -6 and -7 (Bratton and Salvesen, 2010). 
 
Apoptosis is characterised by a series of typical morphological and biochemical 
features, such as nuclear and cytoplasmic condensation, cell shrinkage, DNA 
“laddering” due to its degradation by caspase-activated deoxyribonuclease (CAD), 
fragmentation into membrane-bound apoptotic bodies, and is followed by rapid 
phagocytosis by neighbouring cells for degradation and recycling (Kerr, Wyllie and 
Currie, 1972; Nagata et al., 1998).  





1.2.4.2 γH2A.X in apoptosis 
In 2009, Solier and colleagues discovered a novel pattern of γH2A.X staining 
during early apoptosis, detected by immunofluorescence microscopy. They used 
both cancer cells and normal cells and induced apoptosis by subjecting them to 
treatment with either agonists of the death receptor pathway, TRAIL and Fas-
ligand (FasL), or by using the apoptosis initiator, Staurosporine (Solier and 
Pommier, 2009). 
 
They observed that in contrast to the distinct γH2A.X foci pattern that has 
previously been seen following treatment with IR, which is distributed throughout 
the nucleus during DDR at sites of DSBs, instead that during early initiation of 
apoptosis, γH2A.X is visible at the inner face of the nuclear envelope, in a ring-like 
pattern that they refer to as the “apoptotic ring” (Figure 1-4).  This staining pattern 
was found in both cancer cells and normal cells; it was also observed that after this 
early phase of apoptosis, pan-staining of the nucleus occurred, followed by pan-
staining in the apoptotic bodies (Solier and Pommier, 2009). A later study, by the 
same group, noted that the apoptotic ring pattern of staining is not restricted to the 
extrinsic apoptotic pathway; it was also found to be induced by anticancer agents 
through the intrinsic pathway (Solier and Pommier, 2014). 
 
Interestingly, the same pattern of nuclear peripheral staining was seen when 
staining for DNA-PK kinase, indicating that in contrast to ATM being the 
predominant kinase of H2A.X during the DDR, that DNA-PK may represent the 





predominant kinase of H2A.X during the extrinsic pathway of apoptosis induction 
(Solier and Pommier, 2009). They also found that DNA damaging drugs produced 
two consecutive waves of H2A.X response: a population of cells harbouring 
γH2A.X damage foci that appeared within the first few hours following 15 Gy of 
irradiation, followed by a second population of mostly apoptotic pattern stained 
cells at later times. They also noted that high doses of DNA damaging agents 












In this study and subsequent studies, the apoptotic ring was found to colocalise 
with phosphorylated histone H2B (at serine-14), DDR protein kinases CHK2, ATM, 
DNA-PK, and also with the DNA-PK chaperone, heat shock protein HSP90α, which 
is required for DNA-PK activation (Solier et al., 2012). Though they found that it did 
not colocalise with DDR protein 53BP1, suggesting that there may be a different 
Figure 1-4 Apoptotic ring formation 
A human colon carcinoma HCT116 cell following apoptosis induction with the death receptor ligand, 
TRAIL and stained with antibodies against γH2A.X (left) and total H2A.X (right). Pattern of staining 
shows the apoptotic ring during early apoptosis, in contrast to uniform distribution of total H2A.X 
(Solier and Pommier, 2009) 





molecular mechanism of γH2A.X induction during apoptosis, compared to DSB 
repair (Solier and Pommier, 2009). They subsequently found however, that another 
one of the key proteins in the DDR, MDC1, is also absent from the apoptotic ring 
which could potentially explain the absence of 53BP1 (Solier and Pommier, 2011). 
They went on further to find that during the early phase of apoptosis, MDC1 is 
cleaved by activated caspase-3, abrogating its interaction with γH2A.X and DDR 
factors and thus curtailing any further DNA repair (Solier and Pommier, 2011).   
 
A plausible reason for the apoptotic “ring” is that this is formed in response to the 
DSBs caused by caspase-activated deoxyribonuclease (CAD) during the initiation 
of apoptosis: CAD is normally sequestered in the cytoplasm as an inactive complex 
with its inhibitor ICAD, but is released by caspase-3 cleavage during apoptosis and 
is able to diffuse into the nucleus (Nagata et al., 1998; Rogakou et al., 2000). 
Interestingly, phosphorylation of H2A.X appears to be necessary for DNA cleavage 
by CAD (Lu et al., 2006). 
 
1.3 Phosphorylation of H2A.X at Tyrosine 142 
1.3.1 WSTF phosphorylates Tyrosine 142 
In 2009, studies performed by Xiao and colleagues discovered a novel post-
translational modification of H2A.X: they found that the amino-terminal domain of 
WSTF (Williams-Beuren syndrome transcription factor), a member of the BAZ/WAL 
family chromatin remodelling factors, could phosphorylate the SQEY motif of 
H2A.X at tyrosine 142 (Y142).  





WSTF forms part of the WICH complex (WSTF-ISWI ATP-dependent chromatin-
remodelling complex), believed to be involved in DNA replication and the 
mobilisation of nucleosomes (Xiao et al., 2009). The study went on to demonstrate 
that WSTF co-immunoprecipitates with H2A.X, but not with a Y142F mutant; and 
that small interfering RNA (siRNA) knock down of WSTF significantly reduced the 
Y142 phosphorylation. 
 
1.3.2 Tyrosine phosphorylation reduces following ionising radiation 
To determine a potential role for WSTF and Y142 phosphorylation in the DNA 
damage response, both wild-type and WSTF RNAi cells were subjected to IR. 
Interestingly, it was found that in contrast to the large γH2A.X foci that formed at 
4hrs post-IR and persisted until 12hrs post-IR in the control cells, large foci failed to 
form altogether in the WSTF RNAi cells. This was supported by western blot 
analysis which showed that, in contrast to the increase in γH2A.X seen 1hr post-IR 
and sustained until 12hrs post-IR in wild-type cells, WSTF RNAi cells had an 
increase in γH2A.X at 1hr post-IR but that this was not maintained and had sharply 
decreased by 4hrs post-IR and did not recover (Xiao et al., 2009).  
 
The results of this study therefore suggests that WSTF mediated phosphorylation 
of Y142 has a vital role in the DDR and is necessary to maintain γH2A.X formation. 
Furthermore, it suggests that Y142 is constitutively phosphorylated in primary 
mouse embryonic fibroblast (MEF) cells, and that following IR, pY142 is gradually 
dephosphorylated (Figure 1-5), although there does appear to be some recovery 





after 10hrs. This finding is in part supported by a study by Solier and colleagues 
(2011), in which they found that TRAIL-induced apoptosis caused a decrease in 
Y142 phosphorylation and that Y142 was not associated with the apoptotic ring 













1.3.3 Tyrosine 142 dephosphorylation by Eya phosphatase 
Where Xiao and colleagues looked at the impact of inhibition of Y142 
phosphorylation, Cook and colleagues (2009) investigated the effect of inhibiting 
the removal of Y142 phosphorylation on the DDR. In particular, they explored the 
protein tyrosine phosphatase, Eya (Eyes Absent), as a potential phosphatase of 
Y142.  
 
Figure 1-5  Tyrosine 142 is dephosphorylated following ionising radiation 
Acid-extracted histones, from primary MEF cells, following 10 Gy of ionisising radiation (IR). 
Extracts were separated by SDS-PAGE; immunoblotting for γH2A.X, pY142, and general H2A.X as 
a loading control (Xiao et al., 2009). 
. 





Co-immunoprecipitation studies were performed using HEK293T (293T) embryonic 
kidney cells: these showed that both Eya1 and Eya3 interact with H2A.X under 
DNA damage conditions (IR), but not in control cells. This was supported by 
immunostaining, which revealed that HA (haemagglutinin)-tagged Eya1 or Eya3 












These results suggest that the Eya protein tyrosine phosphatase is recruited to 
H2A.X foci in response to DNA damage. Their studies further went on to 
demonstrate that 293T cells, transfected with siRNA against Eya1 or Eya3, showed 
a significantly increased level of phosphotyrosine. In contrast, control siRNA cells 
and untransfected cells displayed a loss of H2A.X tyrosine phosphorylation 
following IR, supporting the data found by Xiao and colleagues (Figure 1-5) (Cook 
et al., 2009). 
Figure 1-6 Colocalization of Eya1 and Eya3 with γ-H2A.X 
HEK293T cells were transfected with HA-tagged EYA1 or EYA3. 1hr following 5 Gy of ionizing 
radiation, Eya 1/3 co-localises with γH2A.X foci (Cook et al., 2009).   





In further support of the WSTF RNAi results seen by Xiao and colleagues, Cook 
and colleagues found that a flag-tagged H2A.X mutant (Y142F) was 
phosphorylated on S139 at significantly lower levels than the wild-type H2A.X; this 
promotes the suggestion that Y142 phosphorylation plays an important role in 
either maintaining or promoting the γH2A.X formation following DNA damage 
(Cook et al., 2009). 
 
1.3.4 Di-phosphorylation of H2A.X  
Cook and colleagues then went on to investigate a connection between Y142 
dephosphorylation and the apoptotic response.  Consistent with a study that found 
that MDC1 binds directly to γH2A.X (Stucki et al., 2005), Cook and colleagues 
used synthetic peptides corresponding to the C-terminal tail of H2A.X that were 
either phosphorylated at S139 alone (γH2A.X), or di-phosphorylated, 
(pS139pY142), followed by affinity purification with nuclear extracts from gamma 
irradiated 293T cells. Intriguingly, they found that repair protein MDC1, and MRN 
complex proteins (Rad-50 and MREII) interacted with γH2A.X, yet failed to interact 
with the di-phosphorylated peptides (Figure 1-7).   
 
Furthermore, the di-phosphorylated peptides instead interacted with activated c-
Jun N-terminal kinase-1 (JNK-1): an interaction that was not observed with 
γH2A.X.  JNK-1 has been found in previous studies to be involved in the UV 
induced phosphorylation of H2A.X and associated with the induction of apoptosis 
(Lu et al., 2006). 


















Cook and colleagues also used C-terminal peptides that were either 
unphosphorylated on both residues, or where the terminal tyrosine had been 
mutated to alanine (Y142A); in both instances, MDC1 failed to make an interaction. 
This suggests that the unphosphorylated form of Y142 is necessary for MDC1 to 
form an interaction with γH2A.X. Furthermore, they performed pull-down studies 
following siRNA knock down of Eya3 and treatment with 10 Gy of radiation: as 
predicted, there was a loss of interaction between H2A.X and MDC1. This was 
further corroborated by a fluorescence polarisation spectroscopy study, conducted 
by Campbell and colleagues, in which they found a greater than 300-fold reduction 
in the affinity of the MDC1-BRCT domain for γH2A.X, when Y142 was also 
Figure 1-7  Interaction of H2A.X synthetic peptides with either DNA repair proteins or pro-
apoptotic proteins 
Pull-down study with synthetic peptides representing C-terminal of H2A.X ( * depicts a 
phosphorylated residue): γH2A.X interacts with DNA repair factors (MDC1, Rad50, MRE11), 
whereas di-phosphorylated H2A.X interacts with the pro-apoptotic protein, JNK-1 (Cook et al., 
2009). 





phosphorylated. It is therefore suggested that pY142 has a role in blocking the 
binding of MDC1 to undamaged chromatin (Campbell, Edwards and Glover, 2010). 
 
Finally, Cook and colleagues examined the effect of siRNA knock down of Eya on 
apoptosis through a TUNEL assay, following subjection of 293T cells to hypoxia 
treatment. They found that siRNA knock down of either Eya1 or Eya3 caused an 
increase in apoptotic cell death (Cook et al., 2009). 
 
1.3.5 Proposed model of H2A.X in DDR 
In summary of their studies, Cook and colleagues (2009) proposed the following 
model (Figure 1-8): they postulate that H2A.X is phosphorylated at Y142 at basal 
levels in undamaged cells. Upon DNA damage, the presence of pY142 becomes 
critical in making the fundamental decision between DNA damage repair or 
apoptosis. DNA damage activated ATM kinase then phosphorylates and activates 
the Eya tyrosine phosphatase: this functions to dephosphorylate Y142 and allows a 
temporal switch to the mono-phosphorylated form (γH2A.X), thus allowing 
recruitment of MDC1 and repair mediators to γH2A.X at the site of damage.  
However, when the C-terminal tail of H2A.X is di-phosphorylated (di-γH2A.X), 
recruitment of MDC1 is impeded and pro-apoptotic proteins are instead recruited. 
However, this model was not supported by the findings of Solier and colleagues 
(2011), in which they found that TRAIL-induced apoptosis caused a decrease in 
Y142 phosphorylation and that Y142 was not associated with the apoptotic ring, 
suggesting that it may not be the governing determinant of apoptosis induction. 




















1.3.6  Interaction with microcephalin protein (MCPH1) 
Singh and colleagues (2012) sought to elucidate how mediator proteins interpret 
the mono- and di- phosphorylated forms of H2A.X and as such, looked at the role 
of the early DDR protein, microcephalin (MCPH1). The previous studies have 
indicated that pY142 is dephosphorylated gradually in response to DNA damage, 
in contrast to S139 which is phosphorylated rapidly in response to DSBs; therefore, 
they sought to identify a mediator protein capable of dual recognition of the 
overlapping states which could serve to recruit downstream mediator proteins. 
Figure 1-8 Proposed model for Y142 phosphorylation in the regulation of DNA damage repair 
versus apoptosis 
γH2A.X leads to recruitment of MDC1 and the MRN complex for DNA damage repair; whereas di- 
γH2A.X (pSer139pY142) prevents MDC1 recruitment and instead promotes the recruitment of pro-
apoptotic JNK-1 (Cook et al., 2009). 





MCPH1 has three BRCA C-terminal (BRCT) domains; the tandem C-terminal 
BRCT2 and BRCT3 domains have previously found to be necessary for irradiation-
induced foci (IRIF) formation (Jeffers et al., 2008) that colocalise with γH2A.X 
(Wood et al., 2007).  
 
They developed an antibody specific to di-phosphorylated H2A.X to examine its 
role in the DDR and to investigate whether MCPH1 is a binding partner. Their 
results suggest that following 10 Gy irradiation for 1-hr, that there is an initial phase 
of di-phosphorylated H2A.X formation, peaking at 1-hr post-irradiation, which is 
followed by a rapid decline (Figure 1-9). They also observed that following 10 Gy of 
irradiation, a Y142 mutant showed the initial γH2A.X formation following DNA 
damage, however this rapidly reduced to undetectable levels. This supports the 
previous findings (Xiao et al., 2009; Cook et al., 2009) in which it was suggested 
that phosphorylation of Y142 is necessary to maintain γH2A.X formation; however, 








Figure 1-9 Kinetics of di-phosphorylated H2A.X after irradiation 
H2A.X-/- MEF cells with Flag-SBP-tagged wild-type H2A.X were subjected to 10 Gy of irradiation 
for 1hr. Whole cell lysates were immunoblotted for γH2A.X and di-γH2A.X formation (Singh et al., 
2012). 





Using pull-down assays, the group also determined that unlike MDC1, which only 
binds to γH2A.X, MCPH1 immunoprecipitated with both the mono- and di-
phosphorylated forms of H2A.X, but not with pY142 (Singh et al., 2012). 
 
1.3.6.1 Antibody validation 
In order to validate their antibody, Singh and colleagues performed a dot blot with 
peptides corresponding to the different modified states of the C-terminal of H2A.X 
and probed them with the di-phosphorylated H2A.X antibody.  
 
As can be seen at Figure 1-10, their antibody shows some cross-reactivity with 
both γH2A.X and pY142, and this may therefore influence the interpretation of the 












Figure 1-10 The di-phosphorylated H2A.X antibody has some cross-reactivity with γH2A.X 
(pS139) and pY142 
Biotinylated peptides representing either unmodified, or  mono- or di-phosphorylated H2A.X were 
spotted on nitrocellulose membrane and the membrane was then probed with pS139pY142 
antibody, or streptavidin HRP (Singh et al., 2012) 





1.4 Eyes Absent (Eya) Tyrosine Phosphatases  
1.4.1 Background 
The Eyes Absent family of genes (Eya1-4) encode dual function Eya proteins that 
are both transcriptional coactivators and threonine/tyrosine phosphatases. These 
proteins are involved in embryonic organ development, fly eye development, the 
regulation of the innate immune response, cell motility, proliferation, and DNA 
damage repair. They are also implicated in promoting tumour cell migration and 
invasion (Okabe, Sano and Nagata, 2009; Cook et al., 2009; Xiong, Dabbouseh 
and Rebay, 2009; Pandey et al., 2010). Overexpression of Eya has been found in 
a number of human cancers and this elevated expression has been correlated with 
tumour aggressiveness and a poorer prognosis in some instances (Rebay, 2015). 
 
1.4.2 Structure and activity 
The transactivation and threonine phosphatase activity is contained within the 
poorly conserved, 200-300 residue amino-terminal domain; whereas the tyrosine 
phosphatase activity is contained within the conserved, 271-274 residue carboxy-
terminal domain (Rayapureddi et al., 2003).  
 
In a study by Rayapureddi and colleagues, it was found that Eya3, of the 
bacterially generated Eya domains from mouse (Eya1-3), had the most potent 
phosphatase activity. Using phosphatase assays to identify the preferred 
substrates, they found that Eya3 showed no activity towards phosphoserine or 
phosphothreonine, but that it efficiently hydrolysed phosphotyrosine. 





It could also dephosphorylate proteins in 293T cells in a dose-dependent and 
metal-dependent manner (Mg2+ or Mn2+).  
 
Their studies went on further to demonstrate that increased proliferation found in 
cells over-expressing Eya2 and Eya3 was not dependent on the tyrosine 
phosphatase activity. However, this activity of Eya was important for cell migration, 
invasion and transformation (Rayapureddi et al., 2003).  
 
1.4.3 Eya is phosphorylated by ATM/ATR kinases 
Eya3 has previously been identified as a potential substrate for the DDR protein 
kinases ATM and ATR (Matsuoka et al., 2007); Cook and colleagues found that 
Eya is phosphorylated at S219 in response to genotoxic stress (Cook et al., 2009).  
Their studies found that a S219A mutant failed to interact with H2A.X or form 
nuclear foci after IR, unlike that of wild-type Eya (Figure 1-11 (A)). In further 
support of this, the inhibition of ATM/ATR using the PI(3)K inhibitor, caffeine, also 
resulted in a failure of Eya1 or Eya3 to interact with H2A.X following IR (Cook et 
al., 2009) (Figure 1-11 (B)).  
 
Furthermore, the depletion of Eya1 or Eya3 alone, using siRNA, was sufficient to 
prevent tyrosine dephosphorylation, and therefore suggested either a lack of 
compensatory activity between them or that they form a stable complex, with both 
components being required for enzymatic activity (Cook et al., 2009). 
 

















It is therefore speculated that upon DNA damage, Eya is regulated via 
phosphorylation at S219 by ATM/ATR, thus directing its tyrosine phosphatase 
activity towards pY142 and thereby facilitating the recruitment of DNA damage 
repair proteins. Furthermore, that through inhibition of Eya-mediated Y142 
dephosphorylation, the formation of the subsequent di-phosphorylated H2A.X 
would promote the recruitment of pro-apoptotic proteins.  
 
This has potential implications in cancer cells to promote apoptotic death; this 
current study therefore sought to elucidate whether the inhibition of Y142 
dephosphorylation could be pharmaceutically mimicked with Eya inhibitors and 
whether this would result in an increase in cell death. 
Figure 1-11  Eya phosphorylation at Ser-219, by ATM/ATR, is a requirement for H2A.X 
colocalisation 
A. HA-Eya3 mutant (S219A) does not immunoprecipitate with Flag-H2A.X following 5 Gy of ionising 
radiation.  B. HA-Eya1 does not immunoprecipitate with Flag-H2A.X in the presence of PI(3)K 
inhibitor, Caffeine, and following 5 Gy of ionising radiation (also seen for Eya3) (Cook et al., 2009). 
 





1.4.4 Eya Tyrosine Phosphatase Inhibitors 
1.4.4.1 Eya active site 
The Eya protein tyrosine phosphatases (PTPs) belong to the haloacid 
dehalogenase (HAD) type phosphotransferases (Tadjuidje et al., 2012). They 
therefore represent an unconventional target for small molecule PTP inhibitors as, 
unlike all other known PTPs that utilise a cysteine residue for catalysis, these 
metallo-enzymes instead utilise aspartate as an acid catalyst (Rayapureddi et al., 
2005).  
 
1.4.4.2 Inhibitor selection 
An experimental screen of chemical inhibitors, by Tadjuidje and colleagues, found 
that the uricosuric agents Benzbromarone and Benzarone exhibited selectivity for, 
and were potent inhibitors of, the Eya tyrosine phosphatase activity. This was 
brought about by testing the hydrolytic activity of the catalytic domain of Eya3 
(residues 223-510) against the substrate p-nitrophenylphosphate (pNPP), and 
further corroborated using a 10-amino acid phosphopeptide as an alternative 
substrate, one that represented pY142 at the C-terminus of γH2A.X (Figure 1-12).  
 
An MTT assay conducted using a non-transformed mammary epithelial cell line 
(MCF10A) showed that the Eya inhibitors did not lead to any significant effect on 
cell proliferation (Tadjuidje et al., 2012). 
 

















1.5 Project outline 
The study by Cook et al. put forward two key hypotheses: 
1. That knockdown of Eya phosphatase activity led to an increase in apoptosis in 
cells, following damage by hypoxia or IR.  
2. That the mechanism for this was an increase in the level of di-γH2A.X, which 
they proposed to be an epigenetic mark specifically associated with apoptosis. 
The aim of this project was to therefore clarify the role of di-γH2A.X in the DDR, as 
well as in apoptosis. In addition, to test whether Benzbromarone - a 
pharmaceutical inhibitor of Eya - might be a useful adjuvant chemotherapeutic 
agent during treatment with DNA-damaging cancer drugs. 
Figure 1-12 Benzbromarone is a potent inhibitor of Eya3 
A. The IC50 values for Benzbromarone inhibition of Eya3 were calculated to be 8.3μM when using 
pNPP as a substrate and 37μM using a 10-amino acid phosphopeptide representing pY142 as a 
substrate.  B. Increasing concentrations of substrate does not overcome Benzbromarone inhibition 
of Eya3, therefore it is an uncompetitive inhibitor. 





Co-operativity between Benzbromarone and the radiomimetic, chemotherapeutic 
agent, Bleomycin, was first investigated using the cell proliferation assay, MTT. 
The effect on apoptosis was then further assessed using an IncuCyte Live Cell 
Analysis System by detection of Annexin V and cleaved caspase-3/7. 
 
Finally, immunochemical staining was performed to visualise the nuclear 
localisation patterns of both γH2A.X and di-γH2A.X, in cells undergoing both DNA 
repair and in apoptotic cells. For this project, I used a novel polyclonal antibody 
(supplied by Dr. Ellis) that was raised against di-phosphorylated H2A.X. Unlike the 
antibody used in previous published studies, the new antibody shows no cross-











Figure 1-13 Validation of a novel 
polyclonal antibody raised against di-
γH2A.X 
Anti- di-γH2A.X antibody does not cross react 
with H2A.X or γH2A.X peptides. A dilution 
range of peptides, representing either 
unmodified H2A.X (SQEY), γH2A.X (pSQEY) 
or di-phosphorylated H2A.X (pSQEpY) were 
spotted on nitrocellulose membrane and the 
membrane was probed with the di-
phosphorylated H2A.X antibody.  





2 Materials and methods 
2.1 Tissue Culture 
Human Embryonic Kidney (HEK-293T) and Mouse Embryonic Fibroblast (MEF) 
cells were maintained in Dulbecco’s Modified Eagle Medium (DMEM) with 1% L-
Glutamine (ThermoFisher), supplemented with 10% foetal bovine serum (FBS) 
(ThermoFisher) and 1% penicillin/streptomycin (ThermoFisher). Cells were 
cultured at 37°C and 5% CO2 and grown to confluency before splitting for 
passaging, which occurred every 4-days.  
 
2.2 Nuclear protein extraction  
HEK-293T cells were grown in T-175 tissue culture flasks, maintained in DMEM 
with 1% L-Glutamine, supplemented with 10% FBS and 1% penicillin/streptomycin 
at 37°C and 5% CO2. Following treatment with 600IU (264µM) Bleomycin, cells 
were harvested by washing once with phosphate buffered saline (PBS) followed by 
the addition of 0.25% trypsin-EDTA. Cells were centrifuged at 1000 rpm for 5-mins, 
at 4°C, then the pellet washed twice in PBS. The cell pellets were washed again in 
ice cold hypotonic buffer containing 10mM Hepes (pH 7.9), 1.5mM MgCl2, 10mM 
KCl, 1mM dithiothreitol (DTT), 50mM Benzbromarone, 0.5mM 
phenylmethylsulfonyl fluoride (PMSF), and a protease and phosphatase inhibitor 
cocktail (ThermoFisher), then centrifuged again at 1000 rpm for 5-mins, at 4°C.  





Cells were then lysed by resuspending in the hypotonic buffer containing 0.1% NP-
40 and incubation on ice for 30-mins, then mechanical shearing with a dounce 
homogeniser. The nuclei fraction was pelleted by centrifugation at 13,000 rpm for 
10-mins, at 4°C, following which it was washed twice in PBS and then 
resuspended in a hypertonic buffer, for 15-mins on ice, containing 20mM Hepes 
(pH 7.9), 1.5mM MgCl2, 420mM KCl, 25% Glycerol, 1mM DTT, 0.5mM PMSF, 
50μM Benzbromarone, and a protease and phosphatase inhibitor cocktail 
(ThermoFisher). Samples were centrifuged at 13,000 rpm for 10-mins, at 4°C, to 
remove nuclear debris, and the supernatant containing nuclear proteins transferred 
to a fresh tube. The protein concentrations were quantified using a ND-1000 
NanoDrop Spectrophotometer. 
 
2.3 Acid extraction of histones  
HEK-293T cells were seeded at a density of 1 x 106 cells in T-75 tissue culture 
flasks, maintained in DMEM with 1% L-Glutamine, supplemented with 10% FBS 
and 1% penicillin/streptomycin at 37°C and 5% CO2. Cells were treated with/or 
without 8µM of Benzbromarone 24-hrs after seeding. 48-hrs post Benzbromarone 
treatment, cells were treated with/without 5µM of Bleomycin. At each specified 
time-point, the cells were trypsinised and collected in 50ml tubes. Cells were 
centrifuged at 300 rpm for 10-mins and the supernatant discarded; the cell pellet 
was then washed with PBS and re-centrifuged at 300 rpm for 10-mins and the 
supernatant again discarded. The cell pellet was then re-suspended and incubated 
in 1ml of ice cold hypotonic lysis buffer, containing 10mM Tris–Cl (pH 8.0), 1mM 





KCl, 1.5mM MgCl2, 1mM DTT, and a protease and phosphatase inhibitor cocktail 
(ThermoFisher), for 1hr at 4°C on a spinning rotator. The intact nuclei were 
pelleted by centrifugation at 10,000 rpm for 10-mins, at 4°C. The supernatant was 
discarded, the nuclei re-suspended in 400μl of 0.2M sulphuric acid (H2SO4) and 
incubated on a spinning rotator, overnight at 4°C. Samples were centrifuged at 
13,000 rpm for 10-mins, at 4°C, to remove nuclear debris, and the supernatant 
containing histones transferred to a fresh tube; this was then neutralised by adding 
4ul of 5M! sodium hydroxide (NaOH) to 60ul of sample (in 0.2M H2SO4) - final pH-
6.0, and protein concentrations quantified using a ND-1000 NanoDrop 
Spectrophotometer. 
 
2.4 SDS-PAGE and Western blot analysis 
The nuclear / histone extracts were prepared with either: 1) Bolt LDS sample buffer 
(ThermoFisher) with 10% 2-mercaptoethanol, heated at 70°C for 10-mins, followed 
by SDS-PAGE performed on either 10% or 15% handcast polyacrylamide gels with 
NuPage MOPS SDS running buffer containing 50mM MOPS, 50mM Tris Base, 
0.1% SDS, 1mM EDTA, (pH 7.7); or 2) Novex Tris-Glycine SDS sample buffer 
(ThermoFisher) with 50mM DTT, heated at 70°C for 10-mins, followed by SDS-
PAGE performed on a 16% pre-cast Tris-Glycine polyacrylamide gel 
(ThermoFisher) with Novex Tris-Glycine SDS running buffer containing 25mM Tris 
Base, 192mM Glycine, 0.1% SDS, (pH 8.3). Electrophoresis was performed at a 
constant voltage of 100v for 90-mins. After electrophoresis, proteins were 
transferred to a Polyvinylidene Difluoride (PVDF) membrane.  





The PVDF membrane was then blocked in Tris-buffered saline (TBS) with 0.1% 
Tween-20 and 5% BSA for 60-mins, then incubated with either anti-pS139 primary 
antibody (1:5000, mouse monoclonal, PTM Biolabs) or anti-pS139pY142 (1:1000, 
rabbit polyclonal with two purifications, PTM Biolabs), overnight at 4°C. After 
incubation, the membrane was washed four times with TBS with 0.1% Tween-20 
solution for 5-mins each, then incubated with HRP-conjugated secondary antibody 
(1:10,000), raised against the primary antibodies, for 1-hr at room temperature with 
agitation. Finally, the PVDF membrane was washed four times with TBS Tween-20 
for 5-mins each, incubated with enhanced luminol-based detection (ECL) reagent 
and then exposed on a Syngene G:Box-fluorescence imager.  
 
2.5 Cell viability / proliferation assays  
96-well plates were either seeded directly, or prepared by incubating them in a 
1mg/ml solution of Poly-D-Lysine, overnight at 4°C, followed by two washes with 
sterile distilled water and a single wash with 96% ethanol. HEK-293T and MEF 
cells were seeded at a density of 1 x 103 cells per well, in DMEM with 1% L-
Glutamine, supplemented with 10% FBS and 1% penicillin/streptomycin at 37°C 
and 5% CO2. Cells were treated with/without 8μM Benzbromarone and/or serial 
dilutions of Bleomycin (100μl total volume). These were incubated for 5-days, after 
which 1mM of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 
was added to each well (25μl of a 4.8mM stock) and incubated for 4-hrs.  
 





The MTT assay involves the conversion of the water soluble MTT to an insoluble 
formazan. The formazan was then solubilised by addition of a sodium dodecyl 
sulphate (SDS) solution (pH 4.0) containing 20% SDS and 40% dimethylformamide 
(DMF) overnight, and the concentration determined by optical density at 570nm 
using a microplate absorbance reader. 
 
2.6 Apoptosis assays (Annexin V / Cleaved Caspase 3/7) 
96-well plates were prepared by incubating them in a 1mg/ml solution of Poly-D-
Lysine, overnight at 4°C, followed by two washes with sterile distilled water and a 
single wash with 96% ethanol. HEK-293T cells were seeded at a density of 1 x 103 
cells (100μl per well), in DMEM with 1% L-Glutamine, supplemented with 10% FBS 
and 1% penicillin/streptomycin, with/without 8μM of Benzbromarone and incubated 
at 37°C and 5% CO2. 24-hrs later, media was removed from wells and replaced 
with fresh media in combination with 8μM Benzbromarone and/or dilutions of 
Bleomycin. Cells were incubated with either: 1) 1mM of CaCl2 and IncuCyte 
Annexin V cyanine fluorescent dye (1:200, EssenBioScience), which emits a red 
fluorescent signal upon binding to exposed phosphatidylserine (PS); or 2) 5μM 
IncuCyte Caspase-3/7 Reagent (1:1000, EssenBioScience), which crosses the cell 
membrane and can be cleaved by activated caspase-3/7 to release a DNA-binding 
green fluorescent label. Cell growth and apoptosis was monitored using the 
IncuCyte Live-Cell Analysis System, capturing 4 images per well, every 2 to 4 hrs 
at 10x objective. 
 





2.7 Immunofluorescence  
Coverslips were prepared by incubating them in a 1mg/ml solution of Poly-D-
Lysine, overnight at 4°C, followed by two washes with sterile distilled water and a 
single wash with 96% ethanol. Coverslips were place in a CELLBIND 6-well plate 
and HEK-293T cells were seeded at a density of 3 x 105 cells per well, 24-hrs prior 
to treatment with/without 8µM of Benzbromarone and incubated at 37°C and 5% 
CO2. 24-hrs post-Benzbromarone treatment, when the cells had reached ~60% 
confluency, they were treated with/without 5μM of Bleomycin. At each specified 
time-point, the media was removed and cells washed twice with ice cold PBS. 
Cytoplasmic and loosely held nuclear proteins were first extracted by incubating 
the coverslips on ice in 200μl of ice cold cytoskeleton (CSK) buffer, containing 
10mM PIPES, 300mM Sucrose, 100mM NaCl, 3mM MgCl2, 1mM EDTA, with 0.1% 
(V/V) Triton X-100, for 1-min. Coverslips were then washed twice with 1ml of ice 
cold PBS, followed by extraction of the tightly held nuclear proteins by incubating 
the coverslips in CSK buffer with 0.5% (V/V) Triton X-100, on ice for 20-mins. 
Coverslips were washed three times with ice cold PBS and cells fixed by 
incubating them in 4% formaldehyde/PBS at 4°C for 30-mins. Following fixation, 
cells were quenched with 50mM ammonium chloride (NH4Cl), for 15 mins at 4
°C, to 
reduce potential auto-fluorescence, then washed three times with PBS and 
permeabilised with TBS/0.5% Triton X-100 for 10-mins. Coverslips were washed 
three times with TBS and then blocked in TBS with either 1) 0.1% Triton X-100 and 
3% BSA, or 2) 0.1% Triton X-100 and 10% goat serum, at 22°C for 60-mins, to 
reduce potential background staining. 





Coverslips were then incubated in primary antibody diluent (TBS with 0.1% Triton 
X-100 and 3% BSA), with anti-pS139 primary antibody (1:250, mouse monoclonal, 
PTM Biolabs), together with anti-pS139pY142 primary antibody (1:50, rabbit 
polyclonal with two purifications, PTM Biolabs), overnight at 4°C. Coverslips were 
then washed three times with TBS for 5 mins each and incubated in secondary 
antibody diluent (TBS with 0.1% Triton X-100 and 3% BSA) with fluorescein 
isothiocyanate (FITC) conjugated goat anti-rabbit (1:500; Abcam - ab6717) and 
either Alexa Fluor 647 donkey anti-mouse (1:500; ThermoFisher - A31571) or 
Texas Red goat anti-mouse (1:500; Abcam - ab6787) secondary antibodies, at 
room temperature for 1hr. Followed by a further three washes with TBS and then 
mounted onto a glass microscope slide using Vectashield mounting medium 
containing DAPI (4',6-diamidino-2-phenylindole hydrochloride). Imaging was 
conducted on either an Olympus BX-60 epifluorescence microscope equipped with 
a cooled CCD camera, with DAPI, FITC and Cy5 filters; or an or Olympus BX-61 
epifluorescence microscope equipped with a cooled CCD camera, with DAPI, FITC 














3.1 Validating antibodies 
3.1.1 Dot blot 
As previously shown in Figure 1-13, the novel di-γH2A.X antibody was first 
validated for its specificity by dot blot: a dilution range of peptides, representing 
either unmodified H2A.X (SQEY), γH2A.X (pSQEY) or di-phosphorylated H2A.X 
(pSQEpY) were spotted on nitrocellulose membrane and then probed with the anti- 
di-γH2A.X antibody.  
 
Unlike the previously discussed anti- di-γH2A.X antibody used by Singh and 
colleagues (Figure 1-10), the results showed that it was specific for di-
phosphorylated H2A.X (pSQEpY) and that there was no cross-reactivity with the 










Figure 3-1 Validation of a novel polyclonal 
antibody raised against di-γH2A.X 
Anti- di-γH2A.X antibody does not cross react 
with H2A.X or γH2A.X peptides. A dilution 
range of peptides, representing either 
unmodified H2A.X (SQEY), γH2A.X (pSQEY) 
or di-phosphorylated H2A.X (pSQEpY) were 
spotted on nitrocellulose membrane and the 
membrane was probed with the di-
phosphorylated H2A.X antibody.  





3.1.2 Nuclear protein extraction 
To validate the antibody further using western blot analysis, nuclear extracts were 
prepared using a protocol developed for the extraction of nuclei from human tissue 
culture cells (Dignam, Lebovitz and Roeder, 1983). 293T cells were treated with 
600IU (264µM) of Bleomycin, and nuclear proteins extracted between 1-hr and 4-
days after continuous treatment. Both nuclear and cytosolic fractions were then 
separated using SDS-PAGE, transferred to a PVDF membrane and probed using 


















Figure 3-2 γH2A.X and di-γH2A.X expression following Bleomycin treatment 
Di-γH2A.X was seen at the correct molecular weight of ~17kDa, as was γH2A.X; different 
expression levels are also seen for the two different antibodies, verifying that they are not cross-
reacting. HEK293T were treated with 600IU of Bleomycin and nuclear proteins extracted. 38.7μg of 
both nuclear and cytosolic fractions were separated by SDS-PAGE using a 10% handcast gel, and 
probed with either anti-γH2A.X (pS139) or anti- di-γH2A.X (pS139pY142).  
 





From this, it was possible to firstly determine that the di-γH2A.X antibody showed a 
band at the correct molecular weight for H2A.X (~17 kDa). Although separation of 
the nuclear fraction from the cytoplasmic fraction was not completely successful, 
shown from the band seen in the cytosolic fraction at 4-days probed with anti- di-
γH2A.X, it did allow for visualisation of the different expression levels for the two 
different epigenetic states: strong induction of γH2A.X formation is seen at 4-day 
post-treatment. Although it is not seen at earlier time-points, as would be expected 
from the previously published results, earlier induction may not have been visible 
due to masking from the very strong signal at 4-days. In contrast, induction of di-
γH2A.X is seen earlier, at 1-hr post-treatment. Similarly to γH2A.X, the strongest 
expression is at 4-day post-treatment, although with less total di-γH2A.X than 
γH2A.X. At 4-day post treatment with 264µM Bleomycin, the cells would be mostly 
apoptotic, as verified in later results.  
 
3.1.3 Acid extraction of histones 
To optimise extraction of the nuclear histones for better visualisation of di-γH2A.X, 
which is expressed in lower abundance than γH2A.X, an acid extraction protocol 
was next followed. Following hypotonic lysis of 293T cells treated with 5µM 
Bleomycin, histones were extracted using sulfuric acid (H2SO4) and neutralised 
using equivalent volumes of sodium hydroxide (NaOH). Histones were then 
separated using SDS-PAGE, transferred to a PVDF membrane and probed as 
before (Figure 3-3). 
 

























Whereas the previous western blot focussed on histone modification expression at 
just 1-hr and 4-day post-Bleomycin treatment, this experiment observed earlier 
time-points; hence cells were harvested after 2-hrs, 4-hrs and 24-hrs of treatment. 
In addition, instead of using 264µM of Bleomycin as before, which would likely 
cause heavy DNA damage leading to rapid induction of apoptosis, 5μM of 
continuous Bleomycin treatment was used so that the mechanism of early attempts 
at DNA repair could be examined. 
 
Once again, a different pattern of expression can be seen for γH2A.X and di-
γH2A.X, further verifying the antibody specificities.  
Figure 3-3 Acid extraction of histones show a different pattern of expression 
Western blotting demonstrates that di-γH2A.X expression is different to that of γH2A.X. HEK293T 
cells were treated with 5μM of Bleomycin. Cells were harvested at the specified time points and 
histones extracted using H2SO4. 6.3μg of histone extracts were neutralised and separated by SDS-
PAGE using a 15% handcast gel, probed with either anti-γH2A.X (1:5000) or anti- di-γH2A.X 
(1:1000) antibodies, then visualised using chemiluminescence.  
 





A strong induction of both γH2A.X and di-γH2A.X can be seen at 2-hrs post-
treatment, more so with γH2A.X, which decreases at 4-hrs and increases again at 
24-hrs. Di-γH2A.X expression decreases at 4-hrs and only increased again slightly 
at 24-hrs on this occasion. Interestingly, both γH2A.X and di-γH2A.X are seen in 
the control cells, suggesting that the HEK293T cells had some level of endogenous 
DNA damage, possibly from replicative stress. 
 
3.1.4 Peptide competition assay 
As a further verification step, a peptide competition assay was performed by 
western blot analysis. To do this, antibodies are incubated with an excess of 
peptide corresponding to the epitope that is recognised by the antibody; the 
antibody is therefore blocked and no longer available to bind the epitope that is 
present on the membrane. 
 
293T cells were either pre-treated with 8μM Benzbromarone, 24-hrs prior to 
treatment with 5μM Bleomycin, or with 5μM Bleomycin alone. The cells were 
harvested at 30-mins, 1-hr, 4-hrs, and 24-hrs post-Bleomycin treatment. The 4-hr 
and 24-hr cells were rescued 2-hrs post-treatment by removal of Bleomycin and 
replacement of fresh media, either with or without 8μM Benzbromarone. 
 
The cells were then subjected to hypotonic lysis to remove the cytoplasmic 
fraction, followed by acid extraction of the histones, using H2SO4. The extracts 
were neutralised as before, using NaOH, and separated by SDS-PAGE. 





The proteins were transferred to a PVDF membrane and then probed with either 
anti-γH2A.X or anti- di-γH2A.X antibodies. In addition, the di-γH2A.X was pre-
incubated overnight with either di-γH2A.X peptide or γH2A.X peptide, centrifuged 
at 12,000 rpm for 10-mins to pellet the immune complexes and then used to probe 
the PVDF membrane.  
 
However, in order to successfully block the immunising antibody, an excess of 
corresponding peptide should be used, typically between 5-10 times weight/weight 
(w/w) to antibody. Unfortunately, on this occasion only 1 times w/w was used and 
therefore was unlikely to completely block the anti- di-γH2A.X antibody. This is 
reflected in the results shown at Figure 3-4, whereby pre-incubation of di-γH2A.X 
antibody with di-γH2A.X peptide fails to completely block the signal (Figure 3-4 
(D)). Nevertheless, the signal is reduced in comparison to either di-γH2A.X 
antibody on its own, or di-γH2A.X pre-incubated with γH2A.X peptide (Figure 3-4 
(D) as compared to Figure 3-4 (A) and (C) respectively). 
 
Strong induction of γH2A.X is seen at 24-hrs post-Bleomycin treatment (Figure 3-4 
(B)). Interestingly, on the three membranes probed with anti- di-γH2A.X antibody, 
two distinct bands for di-γH2A.X were evident: the expected ~17 kDa, as well as a 
smaller band at ~12 kDa. This cannot be explained at this time and so requires 
further investigation. The co-operativity between Bleomycin and Benzbromarone 
will be discussed in the next section. 
 



































Figure 3-4 Antibody specificity analysed by a peptide competition assay on histone extracts 
Peptide competition assay shows that di-γH2A.X peptide, but not γH2A.X peptide, is competitive for 
anti- di-γH2A.X antibody (A-B) HEK293T cells were treated with 5μM Bleomycin with/without 8μM 
Benzbromarone 24-hrs previously. 3μg of H2SO4 extracted histones were separated by SDS-PAGE, 
using a 16% pre-cast gel and probed with anti-γH2A.X (1:5000) or anti- di-γH2A.X (1:1000) 
antibody. (C) 7.2μg anti- di-γH2A.X antibody was first incubated with 7.2μg of γH2A.X peptide. (D) 
7.2μg anti- di-γH2A.X antibody was first incubated with 7.2μg of di-γH2A.X peptide. Ponceau 
staining of histone extracts shown as a loading control.  





3.2 Co-operativity between Bleomycin and Benzbromarone 
3.2.1 Western blot results 
To assess any co-operativity between Bleomycin and the Eya inhibitor, 
Benzbromarone, the expression levels of γH2A.X and di-γH2A.X were first 
compared by western blot analysis as shown previously.  
 
The western blot at Figure 3-5 is an extended version of that already shown at 
Figure 3-3. From this, it is apparent that induction of γH2A.X is strong at 2-hrs post-
Bleomycin treatment; this then reduces at 4-hrs post-treatment and increases 
again at 24-hrs. Although not a significant difference to that seen with pre-
treatment of Benzbromarone prior to Bleomycin treatment, it does appear that 
inhibition of Eya by Benzbromarone causes slight reduction in γH2A.X levels at 2-
hrs and 4-hrs post-Bleomycin treatment.  
 
This same reduction in γH2A.X expression when pre-treated first with 
Benzbromarone was, however, seen more apparently at 30-mins and 1-hr in 
Figure 3-4 (B), with a clearly visible reduction in γH2A.X at these time-points. In 
this case, cells had been pre-treated with 8μM of Benzbromarone, 24-hrs before 
treatment with 5μM of Bleomycin. A recovery of γH2A.X levels is seen by 4-hrs 
post-treatment, yet by 24-hrs post-treatment, γH2A.X levels are significantly less to 
those that were not first pre-treated with Benzbromarone. In addition, di-γH2A.X 
levels appear to increase with pre-treated of Benzbromarone (Figure 3-4 (A)). 
 


















3.2.2 Cell viability assays 
3.2.2.1 MTT assays 
To test the hypothesis of Cook and colleagues, in that inhibition of the removal of 
pY142 by the Eya phosphatase drives a molecular switch from DNA damage repair 
to apoptosis, pharmaceutical inhibition of Eya with Benzbromarone was used to 
assess the effect on cell viability. To do this, firstly the colorimetric tetrazolium salt 
assay, 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium-bromide (MTT) was 
used: this provides a measurement of metabolically active cells through the 
conversion of MTT to a purple coloured fomazan, the absorbance of which can 
then be read on a spectrophotometer. 
Figure 3-5 Western blot shows slight co-operativity between Bleomycin and Benzbromarone 
Pre-treatment with Benzbromarone before Bleomycin causes slight reduction in γH2A.X expression. 
HEK293T cells were treated with 8μM of Benzbromarone, 48hrs prior to treatment with 5μM of 
Bleomycin. Cells were harvested at the specified time points and histones extracted using H2SO4. 
6.3μg of histone extracts were neutralised and separated by SDS-PAGE, using a 15% handcast gel, 
probed with either anti-γH2A.X (1:250) or anti- di-γH2A.X (1:50) antibodies, then visualised using 
chemiluminescence.  





As Eya phosphatase is known to have many cellular functions, we wanted to first 
determine the maximum concentration of inhibitor that would that have no 
independent effect on cell viability and therefore more likely that any co-operativity 
was a result of the proposed mechanism. An MTT assay was performed on both 
293T and MEF cells, with triplicate technical repeats (Figure 3-6):  from this it could 
be seen that there was ~100% cell viability at ~10μM (in comparison to control 
cells). As a result, 8μM of Benzbromarone was chosen for subsequent assays. 
There was a sharp decline in viability seen between 10 - 200μM in both cell lines, 














Figure 3-6 The effect of Benzbromarone and Dimethylsulfoxide on cell lines in vitro 
Benzbromarone has an IC50 of 28μM in HEK293T cells and 65μM in MEF cells; Dimethylsulfoxide 
(DMSO) has no effect at this concentration of Benzbromarone in MEF cells. HEK293T and MEF 
cells were seeded in a 96-well plate and incubated with a serial dilution of either Benzbromarone; 
MEF cells were treated with an equivalent quantity of DMSO. After 5-days, MTT was added and the 
OD read at 570nm. Cell viability was calculated as a percentage of the untreated cells and each 
data point is an average of the triplicate repeats. Error bars based on standard deviation (SD).  
. 





As Benzbromarone is solubilised in dimethylsulfoxide (DMSO), equivalent dilutions 
of DMSO were used as a vehicle-only control in MEF cells (Figure 3-6): This shows 
a small decline in cell viability between 0.1 - 0.5% DMSO (equivalent to 125 - 
500μM Benzbromarone) and a 60% decrease in cell viability at 2% total DMSO, 
which is equivalent to that which would be in 2mM Benzbromarone. Therefore, the 
decline in cell viability seen at greater than 10μM of Benzbromarone is not 
attributable to the effects of DMSO, other than possibly a small contribution at the 
maximum concentration of Benzbromarone.  
 
MTT assays were then performed in both 293T and MEF cells, using 20μM 
Bleomycin as a starting concentration, with 4-fold serial dilutions and triplicate 
technical repeats. In addition, to determine if pre-treatment with Benzbromarone 
would increase the co-operativity with Bleomycin, by enabling uptake and inhibition 
of the Eya phosphatase prior to DNA damage by Bleomycin, cells were either pre-
treated with Benzbromarone 24-hrs before or at the same as Bleomycin. 
 
Each data point in Figure 3-7 is an average of each triplicate repeat: this MTT 
assay shows no co-operativity between Bleomycin and 8μM Benzbromarone. 
Unexpectedly however, a slight increase in viability is seen in MEF cells treated 
with Benzbromarone, which was seen in biological repeats and is of yet 
unexplained. The IC50 of Bleomycin in 293T cells was found to be 0.08μM, 
whereas MEF cells have slightly higher tolerance with an IC50 of 0.5μM. 
 




























Figure 3-7 Cell viability assays (MTT) show no cooperativity between Bleomycin and 8μM of 
Benzbromarone 
Co-treatment with Benzbromarone does not decrease the final percentage of viable cells. The IC50 
of Bleomycin is 0.08μM in 293T cells and 0.5μM in MEF cells. HEK-293T cells (top) and MEF cells 
(bottom) were seeded in 96-well plates and incubated with 8μM of Benzbromarone either 24hrs 
before or at the same time as a serial dilution of Bleomycin. After 5-days, MTT was added and the 
OD read at 570nm. Cell viability was calculated as a percentage of the untreated cells. Error bars 
based on SD of triplicate repeats. 





For subsequent MTT assays, 293T cells were instead treated with a pulse 
treatment of Bleomycin, which was removed after 2-hrs and replaced with fresh 
media with/without 8μM of Benzbromarone. The 96-well plate was first treated with 
Poly-D-Lysine, therefore the effect this may have on cell proliferation was 
measured (Figure 6-1 – Supplementary data). Cells were then either pre-treated 
with 8μM Benzbromarone 24-hrs before, at the same time, or 2-hrs after treatment 
with Bleomycin. The results seen indicate that again, there was no effect on cell 
viability by using a pulse treatment of Bleomycin, or by varying the timing of 
Benzbromarone administration.  A pulse treatment of Bleomycin increased the 
IC50 to 0.65μM in 293T cells, compared to 0.08μM with continuous exposure. 













Figure 3-8 MTT assay shows no cooperativity between Benzbromarone and a pulse 
treatment of Bleomycin 
Varying the timing of Benzbromarone co-treatment does not decrease the final percentage of 
viable cells; IC50 of Bleomycin with recovery is 0.65µM. HEK-293T cells were seeded as before 
and incubated with 8μM of Benzbromarone either 24hrs before or at the same time as a serial 
dilution of Bleomycin. Media was changed after 2hrs and replaced with fresh media, with/without 
8μM of Benzbromarone. After 5-days, MTT was added and the OD read at 570nm.  





3.2.2.2 Annexin V 
To evaluate the induction of Bleomycin-induced apoptosis in cell culture, 293T cells 
were seeded in quadruple technical repeats in Poly-D-Lysine treated 96-well 
plates, either with or without 8μM of Benzbromarone. 24-hrs later, media was 
removed from wells and replaced with fresh media in combination with 8μM 
Benzbromarone and/or serial dilutions of Bleomycin. In addition, cells were 
incubated with 1mM of CaCl2 and IncuCyte Annexin V cyanine fluorescent dye, 
which emits a red fluorescent signal upon binding to exposed phosphatidylserine 
(PS); PS is a marker of apoptotic cells and is externalised and displayed on the cell 
surface as an “eat-me” signal to phagocytes. 
 
Cell growth and apoptosis was then monitored using the IncuCyte Live-
Cell Analysis System, capturing 4 images per well, every 3-hrs at 10x objective for 
86-hrs. The detection of both fluorescent signal and phase confluency was 
analysed first as an average of the 4-images per time point. These were then 
calculated as a ratio of Annexin V signal to phase confluency for each repeat, then 
an average taken across the quadruple repeats; this was then plotted for each 
dilution of Bleomycin. Graphs for 6.25μM and 25μM of Bleomycin are shown at 
Figure 3-9, which are representative of all concentrations: 6.25μM of Bleomycin 
was found to induce apoptosis in 9.89 ± 0.18% of cells at 86-hrs, and in 15.62 ± 
3.26% of cells at 25μM. No increase in apoptosis was seen by co-treating with 8μM 
of Benzbromarone, or in the Benzbromarone only control sample. 
 



































Figure 3-9 Apoptosis measured by Annexin V detection 
There is no increase in apoptosis, as measure by Annexin V detection, by co-treating with 
Bleomycin and Benzbromarone. HEK293T cells were seeded in quadruple repeats in a 96-well 
plate, 1000 cells per well, with/without 8μM Benzbromarone. 24hrs later, cells were treated with a 
serial dilution of Bleomycin and incubated with Annexin V reagent in an IncuCyte Live-Cell Analysis 
System. Cell growth and apoptosis was monitored by capturing 4 images per well, every 3 hrs at 
10x objective. Time elapsed represents time post-Bleomycin treatment. Error bars based on SD.  





3.2.2.3 Cleaved Caspase 3/7 
As a further evaluation of apoptosis induction, 293T cells were seeded and treated 
in the same manner as with Annexin V reagent. This time however, the cells were 
incubated with IncuCyte cleaved caspase-3/7 reagent; this reagent crosses the cell 
membrane where it can be cleaved by activated caspase-3/7 to release a DNA-
binding green fluorescent label. Cell growth and apoptosis were monitored as 
before, capturing 4 images per well every 2-hrs, this time for 106-hrs. 
 
Analysis was conducted in the same way as before (Figure 3-10). Shown first are 
293T cells treated with either: 6.25μM of Bleomycin only; pre-treated with 8μM of 
Benzbromarone 24-hrs prior to treatment with 6.25µM Bleomycin; or with 8μM of 
Benzbromarone at the same time as 6.25µM Bleomycin. At 86-hrs post-Bleomycin 
treatment, the percentage of apoptosis induction was found to be 5.75 ± 0.37%; 
5.78 ± 0.5%; and 5.13 ± 0.54% respectively. However, at 106-hrs, it was 14.87 ± 
0.78%; 18.38 ± 4.23%; and 20.82 ± 1.29% respectively. The second graph shows 
293T cells treated as above, but with 25μM of Bleomycin. At 86-hrs of post-
Bleomycin treatment, the percentage of apoptosis induction was: 10.21 ± 3.46%; 
12.78 ± 5.49%; and 20.95 ± 0.78% respectively. However, at 106-hrs, it was 21.04 
± 8.27%; 30.82 ± 13.09%; and 49.46 ± 5.01% respectively. Therefore, co-treatment 
of 25μM Bleomycin with 8μM Benzbromarone increased apoptosis more than 2-
fold at 106-hrs. This was repeated with a pulse treatment of Bleomycin for 2-hrs 
(Figure 6-2- Supplementary data). A similar difference in apoptosis induction was 
found, although with less total apoptosis, as would be expected. 


































Figure 3-10 Apoptosis measured by cleaved Caspase 3/7 detection 
Co-treatment of Bleomycin with 8μM of Benzbromarone increases apoptosis. HEK293T cells were 
seeded in quadruple repeats in a 96-well plate, 2000 cells per well, with/without 8μM 
Benzbromarone. 24hrs later, cells were treated with a serial dilution of Bleomycin and incubated 
with Caspase 3/7 reagent in an IncuCyte Live-Cell Analysis System for 106-hrs. Cell growth and 
apoptosis was monitored by capturing 4 images per well, every 2 hrs at 10x objective. Time 
elapsed represents time post-Bleomycin treatment. Error bars based on SD.  






To visualise the nuclear localisation patterns of γH2A.X and di-γH2A.X, 293T cells 
were grown on Poly-D-Lysine treated coverslips in a 6-well plate, until they 
reached ~60% confluency, at which point they were treated 5μM of Bleomycin for 
2-hrs. The Bleomycin was removed and replaced with fresh media to allow a 
further 2-hr recovery period before extraction of the cytoplasmic and nuclear 
proteins using cytoskeleton (CSK) buffer. Following formaldehyde fixation, cells 
were quenched with ammonium chloride (NH4Cl), permeabilised and 
immunofluorescence performed with anti-γH2A.X and anti- di-γH2A.X primary 
antibodies. Anti-γH2A.X was then labelled with AlexaFluor-conjugated secondary 
antibody; anti- di-γH2A.X was labelled with FITC-conjugated secondary antibody. 
 
The results are seen at Figure 3-11. Figure A1 is a field view of untreated cells: of 
the 24 visible cells, 8 cells along the centre of the field show evidence of active 
DNA damage repair in the form of γH2A.X staining, ranging from 3-14 visible foci 
per cell. Consistent with western blot analysis, this again suggests some level of 
endogenous DNA damage in resting cells. Foci of di-γH2A.X are also visible in low 
abundance where γH2A.X is not visible, however the γH2A.X stained cells also 
stain highly for di-γH2A.X, demonstrating that di-γH2A.X foci increase as γ-H2A.X 
foci increase. Most intriguingly however, the majority of γ-H2A.X foci appear to be 
flanked by an adjacent di-γH2A.X focus that is in very close proximity to, but does 
not co-localise with γH2A.X. This is seen more clearly in the higher magnification of 
Cell 1 and Cell 2, at Figures A2 and A3 respectively.  




















































Figure B1 and B2 show the same field view of cells at 4-hr post-Bleomycin 
treatment: Figure B1 is at low gain and shows an apoptotic cell in the top left, 
stained highly with both γH2A.X and di-γH2A.X. The high gain of the same image, 
at Figure B2, reveals that in fact several of the cells are in various stages of DNA 
damage repair, ranging from small, distinct foci, to diffuse staining. Close-ups of 
cells 1-3 at Figures B3-B5 reveal the same pattern of staining seen previously, with 
di-γH2A.X foci seen adjacent to, but not co-localising with di-γH2A.X foci. 
 
A biological repeat was conducted to evaluate whether this localisation pattern was 
consistent, the results of which are shown at Figure 3-12. This revealed the same 
pattern of adjacent staining of γH2A.X and di-γH2A.X in cells both undergoing DNA 
damage repair, as well an interspersed signal seen in apoptotic cells (Figure C1-
C2). In addition to validating the authenticity of the previously seen results, a 
further intriguing finding was noticed in Figure A2, in which di-γH2A.X appears to 
be interdigitating with γH2A.X. 
Figure 3-11 Immunofluorescence shows adjacent localisation of γH2A.X and di-γH2A.X 
Nuclei staining of HEK293T cells undergoing DNA damage repair shows that di-γH2A.X localises 
adjacent to γH2A.X. (A1) Untreated cells shown in a field view have visible signs of DNA repair foci 
(A2-3) Close-up view of Cell 1 and 2 from (A1) (B1-B2) Field view of cells 4-hr post-Bleomycin 
treatment, shown in low-gain and high-gain (B3-B5) Close-up view of Cells 1-3 from (B1-B2). Cells 
were grown on coverslips and either untreated, or treated with 5μM of Bleomycin for 2-hrs. 
Bleomycin was removed and media replaced for a further 2-hrs before extraction of the cytoplasmic 
and nuclear proteins using CSK buffer. Nuclei were fixed in PFA, quenched with NH4Cl and 
permeabilised. Nuclei were blocked with 3% BSA and stained with anti-γH2A.X (1:250) and anti- di-
γH2A.X (1:50) primary antibodies. Anti-γH2A.X labelled with AlexaFluor-conjugated secondary 
antibody (1:10,000); anti- di-γH2A.X labelled with FITC-conjugated secondary antibody (1:10,000);  
imaging on an Olympus BX-60 epifluorescence microscope with DAPI, FITC and Cy5 filters. 
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Figure 3-12 Immunofluorescence biological repeats show same adjacent localisation of 
γH2A.X and di-γH2A.X 
Nuclei staining of HEK293T cells show 1) cells undergoing DNA damage repair whereby di-γH2A.X 
localises in small, distinct foci adjacent to γH2A.X and 2) that there is interspersed and diffuse 
staining of γH2A.X and di-γH2A.X in apoptotic cells. (A1) Standard view of a pair of nuclei 4-hr post-
Bleomycin treatment showing visible signs of DNA repair foci. (A2-A3) Close-up view of different 
regions of (A1), showing interdigitating and adjacent signals respectively. (B1) image of same pair 
of nuclei as in (A1) but taken in a different plane of focus and showing additional repair foci. (B2-
B3) Close-up view of repair foci seen in (B1). (C1) Standard view of apoptotic cells showing the 
characteristic “apoptotic ring”. (C2) Close-up view of (C1) showing interspersed signal of γH2A.X 
and di-γH2A.X. Cells were grown on coverslips and either left untreated, or treated with 5μM of 
Bleomycin for 2-hrs. Bleomycin was removed and replaced with fresh media for a further 2-hrs 
before extraction of the cytoplasmic and nuclear proteins using cytoskeleton (CSK) buffer. Nuclei 
were fixed in PFA, quenched with NH4Cl and permeabilised. Nuclei were blocked with 10% goat 
serum and stained with anti-γH2A.X (1:250) and anti- di-γH2A.X (1:50) primary antibodies. Anti-
γH2A.X labelled with Texas Red-conjugated secondary antibody (1:10,000); anti- di-γH2A.X 
labelled with FITC-conjugated secondary antibody (1:10,000). Imaging conducted on an Olympus 
BX-61 epifluorescence microscope equipped with a cooled CCD camera, with DAPI, FITC and 






















4.1 Antibody validation 
This study used a novel antibody raised against the di-phosphorylated form of 
H2A.X. The specificity of this was validated by dot blot and western blot analysis, 
peptide competition assays and immunochemical staining: dot blots showed that it 
does not cross-react with unphosphorylated H2A.X, or H2A.X phosphorylated at 
only S139 or Y142; western blot analysis revealed a band at the correct molecular 
weight with a pattern of induction that was distinct from γH2A.X; peptide 
competition assays showed a reduction in signal using a di-γH2A.X, but not 
γH2A.X peptide; and immunfluorescent staining of 293T cells show that it does not 
co-localise with γH2A.X and therefore has distinct epitope recognition. 
 
4.2 Co-operativity of Benzbromarone 
4.2.1 Cell viability assays 
The first hypothesis of Cook et al. was that knockdown of Eya phosphatase activity 
led to an increase in apoptosis in 293T cells following DNA damage by 20-hrs of 
hypoxic conditions, or 5 Gy of ionising radiation. This project consequently sought 
to elucidate whether pharmaceutical inhibition of the Eya phosphatase could 
similarly lead to an increase in apoptosis following Bleomycin-induced DNA 
damage.  
 





Eya 1-4 proteins are both transcriptional coactivators and tyrosine phosphatases, 
of which Eya3 has the most potent tyrosine phosphatase activity. Cell proliferation 
is not dependent on the tyrosine phosphatase activity, however, cell migration is 
(Rayapureddi et al., 2003).  
 
To test the hypothesis of Cook et al., a concentration of Benzbromarone was 
selected that was found to have no independent effect on cell viability; thus any co-
operativity could be attributed to the proposed mechanism, in that di-
phosphorylated H2A.X leads to recruitment of pro-apoptotic JNK-1 with 
subsequent apoptosis. 
 
A concentration of 8μM was subsequently selected and tested first by MTT assay. 
By incubating both 293T and MEF cells with a serial dilution of Bleomycin, either in 
the absence or presence of 8μM Benzbromarone, no effect on cell proliferation 
was observed. However, MTT assays afford a measurement of cell proliferation by 
determining the number of metabolically active cells at the end of the incubation 
period, but do not quantify apoptosis induction.  
 
Nevertheless, this concentration of Benzbromarone was found to have some co-
operativity in apoptosis assays conducted with an IncuCyte live-cell analysis 
system. Analysis was first performed by detection of an Annexin V cyanine 
fluorescent dye, which has high affinity for a marker of apoptosis, 
phosphatidylserine (PS).  





Observations were first made over an 86-hr period, whereby no increase in PS 
detection was found by co-treating cells with Bleomycin and 8μM of 
Benzbromarone.  
 
Yet when this was repeated using a further marker of apoptosis, cleaved caspase-
3/7, a more than 2-fold increase in apoptosis was achieved after 106-hrs, by co-
administration of 25μM of Bleomycin with 8μM of Benzbromarone. Rather than a 
difference in selectivity of the different apoptotic markers, the co-operativity found 
instead by cleaved caspase-3/7 detection is likely due to the extended analysis 
period: as at 86-hrs post-treatment, there was also little difference seen by 
caspase-3/7 detection. In support of this, studies by Varmark et al. (2009) 
assessed the long-term viability and proliferation of Bleomycin-treated human 
colon cancer (HCT116) cells: it was found that cell death occurred after an 
interphase delay of between 5–70 hrs. Interestingly, progression through mitosis 
following Bleomycin treatment was found to initiate a cell death response, linked to 
a significant increase in apoptosis. 
 
In our study, 6.25μM of Bleomycin was found to induce apoptosis in 5.75 ± 0.37% 
at 86-hrs. This is also consistent with findings by Varmark et al. that 10μg/ml of 
Bleomycin (equivalent to 6.2μM) induced blocks in G1 and G2 progression, 
indicative of checkpoint activation at these two control points, but did not trigger 
high levels of cell death. This can therefore be considered a suitable concentration 
for the studies of early DNA damage repair mechanisms.  





Since 8μM of Benzbromarone was shown to cause no independent increase in cell 
death, the increase found by co-administration could viably result from the 
mechanism proposed by Cook et al., whereby inhibition of pY142 removal could 
lead to pro-apoptotic JNK-1 with subsequent apoptosis. 
 
Unexpectedly, it was found that incubating cells with Benzbromarone at the same 
time as 25μM Bleomycin caused a larger increase in apoptosis than pre-treating 
cells with Benzbromarone 24-hrs prior to treatment with Bleomycin (49.46 ± 5.01% 
and 30.82 ± 13.09% respectively, at 106-hrs post-treatment). It was postulated that 
pre-treatment would maximise any cooperativity between Benzbromarone and 
Bleomycin by ensuring that Eya phosphatase was inhibited prior to DNA damage 
occurring.  However, the half-life of Benzbromarone under cell culture conditions is 
unknown, and it may instead be that in the pre-treated sample, the Benzbromarone 
was degraded or metabolised prior to Bleomycin administration. 
 
4.2.1.1 Cooperativity assays: limitations and future directions 
4.2.1.1.1 Direct toxic effects of Benzbromarone 
Benzbromarone is a uricosuric agent which acts by reducing the proximal tubular 
reabsorption of uric acid, however treatment with Benzbromarone or the non–
halogenated Benzbromarone derivative, Benzarone, can be associated with 
hepatic injury through mitochondrial damage.  





The mechanism of this has been determined in that they act as inhibitors of both 
the mitochondrial respiratory chain and β-oxidation, which leads to the uncoupling 
of oxidative phosphorylation.  
 
In addition, they cause an increase in reactive oxygen species (ROS) and induce 
leakage of cytochrome c from the mitochondria, triggering apoptosis through 
caspase activation (Kaufmann et al., 2005). In a study of hepatotoxicity in rats, it 
was found that 20μM of Benzbromarone caused an 81% decrease in mitochondrial 
membrane potential, and a 54% decrease at the same concentration of 
Benzarone. Furthermore, 100μM of Benzbromarone or Benzarone increased ROS 
and induced leakage of cytochrome c from the mitochondria, and subsequent 
apoptosis (Kaufmann et al., 2005). In flow cytometry studies using staining with 
Annexin V and propidium iodide, they showed that only 11% of rat hepatocytes that 
were exposed to 100μM of Benzbromarone were viable after 8-hr exposure. 
 
In our studies, we did not investigate the direct toxicity effects of Benzbromarone, 
however we found that in our MTT assays, the IC50 of Benzbromarone was 28μM 
in 293T cells and 65μM in MEF cells, indicating that higher doses of 
Benzbromarone either directly kill these cell types or at least inhibit their 
proliferation.  At present, we cannot tell whether these are direct toxicity effects of 
Benzbromarone or whether they are due to “on-target” effects of Benzbromarone in 
inhibiting Eya phosphatase activity (see next section). 
 





4.2.1.1.2 IC50 of Benzbromarone 
Whilst the IC50 for inhibition of Eya phosphatase by Benzbromarone has been 
found to be 8.1μM (7.4 - 9.3μM), this was measured for pNPP hydrolysis by Eya3 
(Pandey et al., 2013). Though using a phosphopeptide representing the last 10 
amino acids of H2A.X, the IC50 of Benzbromarone inhibition of human Eya3 was 
instead found to be 37μM (Tadjuidje et al., 2012). In our study, we deliberately 
chose the highest concentration of Benzbromarone that had no independent effect 
on cell viability, so that any co-operativity could be attributed to the mechanism 
proposed by Cook et al.  
 
The chosen dose (8μM) is approximately the measured IC50 for inhibition of pNPP 
hydrolysis by Eya3, but is well below the measured IC50 of Benzbromarone when 
acting on H2A.X phosphopeptides, Thus, it is likely that only partial inhibition of 
Eya phosphotyrosine phosphatase activity had been achieved. It is potentially 
interesting that in the Benzbromarone-only arm of the MTT experiments, the IC50 
of Benzbromarone was found to be 28μM in 293T cells and 65μM in MEF cells, i.e. 
a similar order of magnitude to the IC50 for inhibiting H2A.X phosphopeptide 
hydrolysis.  It is possible that the growth inhibition seen in the MTT assays was in 
fact a consequence of “on-target” inhibition of Eya phosphatase activity, triggering 
apoptosis in response to endogenous double strand breaks. The difference in 
susceptibility between 293Ts and MEFs would then be attributable to differing 
levels of endogenous DNA damage – this could be tested in future experiments. 





Additionally, to further assess whether Benzbromarone might still be a useful 
adjuvant chemotherapeutic agent during treatment with DNA-damaging cancer 
drugs, it would be of interest to repeat the cell viability assays, but using a higher 
concentration of Benzbromarone, at or around the IC50 for each cell type tested. 
 
4.2.1.1.3 Alternative pharmacological methods of Eya inhibition 
Benzbromarone was chosen for this study as it was found to be the most potent 
inhibitor of Eya phosphatase, with IC50s as shown above. However, it has a short 
plasma elimination half-life of approximately 3-hrs (Walter-Sack et al., 1990; de 
Vries et al., 1993), metabolised predominantly by cytochrome P450(CYP)2C9 in 
vitro (Uchida et al., 2010). In contrast, the major metabolite of Benzbromarone, 6-
hydroxybenzbromarone, has an increased half-life of approximately 30-hours 
(Uchida et al., 2010). Although this is a less potent inhibitor of Eya, with an IC50 of 
21.5μM (18.3– 25.3μM) measured by Eya3 mediated pNPP hydrolysis (Pandey et 
al., 2013), it was also found to be a significantly more potent inhibitor of cell 
migration, tubulogenesis, and angiogenesis than Benzbromarone or its other 
derivates. Taken together, this may make 6-hydroxybenzbromarone an interesting 
candidate for future studies as a useful adjuvant chemotherapeutic agent. 
Additionally, a novel benzofuran derivative, BL-038 (2-amino-3-(2,6-
dichlorophenyl)-6-(4-methoxyphenyl)benzofuran-4-yl acetate), was recently 
evaluated for its effects in human chondrosarcoma cells.  





This was found to cause apoptosis in two human chondrosarcoma cell lines, with 
an IC50 between 1.8 - 2.2μM by MTT assay, but did not affect the viability of 
normal primary chondrocytes. Apoptosis induction was found to be through 
increased ROS production, decreased mitochondrial membrane potential, 
downregulation of anti-apoptotic proteins (Bcl-2, Bcl-xL), and upregulation of pro-
apoptotic protein (Bax, Bak and Bcl-2) (Liu et al., 2016). 
 
4.2.1.1.4 Alternative non-pharmacological methods of Eya inhibition 
In view of the many functions of Eya, inhibition of which may result in independent 
initiation of apoptosis, an alternative to studying the involvement of pY142 
phosphorylation in the decision between DNA-repair and apoptosis could be by 
selective inhibition of the phosphatase function of Eya, by mutation.  
 
The nucleophilic acid in the first motif of the C-terminal Eya domain is the most 
commonly mutated to form a “phosphatase-dead” Eya, as shown in Figure 4-1  
(Rebay, 2015). Though, there is debate about Eya’s phosphatase activity being 
intertwined with its transcriptional activity; for example, one study found that a 
phosphatase-dead Eya failed to recruit polymerase II (Pol II) and the coactivator 
CBP in a transcriptional reporter assay, leading to the conclusion that the 
phosphatase function was in fact necessary for the transcriptional activation of 
Six1-Dach (Li et al., 2003). 
 





However, a gene targeting approach to reducing Eya activity is further complicated 
by the presence of four paralogous genes that may complement each other in 
some cell types: it may be that several family members would need to be targeted 












4.2.2 Western blot analysis 
4.2.2.1 Intrinsic DNA damage in 293T cells 
Both western blot analysis and immunofluorescent studies showed evidence of 
γH2A.X and equally di-γH2A.X, pre-existing in untreated control cells. This 
suggests a level of endogenous DNA damage in resting 293T cells, which could be 
a result of replicative stress or culture conditions. MEF cells were not used for 
western blot or immunofluorescence analysis, but it would be of interest to 
compare results between the two cell lines in future studies. 
Figure 4-1 The functional domains of Eya family proteins 
The phosphotyrosine (pY) domain of Eya are depicted as dark bars within the Eya domain (ED) at 
the C-terminal. The nucleophilic aspartic acid in the first motif is the most commonly mutated to 
form a “phosphatase-dead” Eya mutant (for example, D322 in human Eya1) (Rebay, 2015). 
 





4.2.2.2 Kinetics of pS139 phosphorylation 
Rapid and extensive phosphorylation on S139 (γH2A.X) occurs following DSB 
induction, followed by dephosphorylation (Rogakou et al., 1998). The time-course 
for the induction and disappearance of γH2A.X foci was investigated in peripheral 
lymphocytes and found that unlike both IR treatment and UVB exposure, which 
cause maximal γH2A.X foci at 30-min post-exposure (Kinner et al., 2008), 
Bleomycin induces a dose-dependent significant increase in γH2A.X foci at 1-hr 
post-treatment, with maximal induction seen at 2-hrs; followed by a progressive 
decrease at 3-hrs and 4-hrs (Scarpato et al., 2013).  
 
However, this depiction of γH2A.X kinetics is complicated by the findings of Ding et 
al. (2016). Shown in Figure 4-2, following X-ray irradiation of human peripheral 
blood lymphocytes, γH2A.X foci formation and pan-nuclear γH2A.X staining has 
two distinct kinetic patterns. The kinetics of γH2A.X foci formation was consistent 
with previous findings, with a peak induced rapidly after irradiation followed by an 
almost equally rapid decrease. In contrast, pan-nuclear γH2A.X staining increased 
steadily and was maintained, peaking at 24-hrs post-irradiation. Moreover, pan-
nuclear γH2A.X staining was found to correspond with TUNEL staining, indicating 
that this staining is associated with apoptosis (Ding et al., 2016). 
 
In our study, the kinetics of pS139 induction was evaluated over either 24-hrs or 4-
days post-Bleomycin treatment, with inconsistent findings. 
 




















In this study, induction was investigated over 24-hrs, by acid extraction of histones 
at 2-hrs, 4-hrs and 24-hrs post-treatment with 5μM of Bleomycin (Figure 3-3): 
maximal pS139 induction was seen at 2-hrs, followed by a decline at 4-hrs then a 
further recovery to the maximal induction, at 24-hrs. Following the kinetics shown 
at Figure 4-2, this could be a result of extensive initial repair foci formation at 2-hrs, 
which decline significantly by 4-hrs; the strong signal reoccurring at 24-hrs is then 
likely to be a result of pan-nuclear γH2A.X in the apoptotic population.  
 
Figure 4-2 Kinetics of X-irradiation induced pan-nuclear γ-H2A.X vs γ-H2A.X foci formation 
Resting human peripheral blood lymphocytes (HPBLs) were exposed to 0.5 Gy of X-ray irradiation. 
Foci of γH2A.X and pan-nuclear γH2A.X were quantified by counting 1000-5000 HPBLs at each 
time point. γH2A.X foci formation occurred rapidly, peaking shortly after irradiation, followed by a 
rapid decline. Whereas, pan-nuclear γH2A.X increased steadily post-irradiation, peaking at 24-hr 
post-exposure (Ding et al., 2016). 
 





However, in a further 24-hr study, also using acid extracted histones but at 30-
mins, 1-hr, 4-hrs and 24-hrs post-treatment with 5μM of Bleomycin (Figure 3-4), 
strong induction was seen at 24-hrs but not before. Strangely, there was also 
higher levels of γH2A.X in the control cells than that seen in the early time-points of 
Bleomycin treatment.  
 
During the 4-day study, 293T cells had been treated with 264μM of Bleomycin, 
likely to induce irreparable DNA damage and apoptosis in the entire population. 
Measurements were taken at just 1-hr and 4-days, and this time by nuclear protein 
extraction (Figure 3-2): strong induction was seen at 4-days, consistent with an 
entirely apoptotic population, yet no induction was seen at 1-hrs; though this earlier 
signal may have been masked by the very strong signal at 4-days. 
 
Co-operativity between Bleomycin and Benzbromarone was seen, in that γH2A.X 
levels were decreased at 30-mins and 1-hr by treating cells with 8μM of 
Benzbromarone 24-hrs prior to 5μM of Bleomycin, and although some recovery 
was seen by 24-hrs, it was significantly less to that seen at 24-hrs with Bleomycin 
alone (Figure 3-4).  In addition, there appeared to be an increase in di-γH2A.X 
through co-treatment with Benzbromarone. Thus, this could be a consequence of 
the conversion of pre-existing pY142 to di-γH2A.X following DNA damage, with 
inhibition of Eya abrogating its conversion to pS139. 
 
 





4.2.2.3 Kinetics of pY142 phosphorylation and di-γH2A.X formation 
Elucidating the kinetics of pY142 and di-γH2A.X phosphorylation has been 
somewhat hindered in past studies due to lack of specificity of antibodies. 
 
Studies conducted by Xiao et al. suggest that Y142 is constitutively phosphorylated 
in MEF cells, and that following IR, pY142 is gradually dephosphorylated (Figure 
1-5); Solier and colleagues also found that TRAIL-induced apoptosis caused a 
decrease in Y142 phosphorylation.  
 
Singh et al. developed an antibody specific to di-phosphorylated H2A.X and their 
findings suggest that there is an initial phase of di-γH2A.X formation 1-hr post-
irradiation, followed by a rapid decline (Figure 1-9). However, their study was only 
conducted over 10-hrs and their antibody cross-reacts with both pS139 and pY142. 
 
Using the novel antibody raised against di-γH2A.X in this study, there was again 
inconsistent results. In some instances, there was strong induction at either 1-hr or 
2-hrs post-Bleomycin treatment (Figure 3-3), followed by a rapid decline (as found 
by Singh et al.); in other instances, strongest induction was found at either 24-hrs 
(Figure 3-4) or 4-days (Figure 3-2). This may suggest however, that di-γH2A.X has 
roles in both early stages of the DDR, as well as later roles in apoptosis. 
 
As mentioned previously, there also appeared to be some increase in di-γH2A.X 
formation through co-treatment of Bleomycin with Benzbromarone. 





4.2.2.4 Kinetics of pY142 de-phosphorylation  
A study conducted by Krishnan et al. (2009) looked further at the 
dephosphorylation of pY142 by Eya2 and Eya3 phosphatases, which corroborated 
findings that they have specificity for Y142 in vitro.  
 
By testing synthetic peptides corresponding to either pS139, pY142 or 
pS139pY142 (di-γH2A.X) as substrates of Eya2 and Eya3, found that: both Eya2 
and Eya3 were able to rapidly dephosphorylate pY142 (Km 1.9μm and 1.8μm 
respectively) but not pS139 (Km 80μm and 72μm), and could also dephosphorylate 
pS139pY142, yet with lower affinity than seen with pY142 (Km 3.8μM and 3.5μM). 
Furthermore, in support of previous findings, siRNA inhibition of Eya lead to an 
increase in basal levels of pY142, as shown by western blot analysis, and inhibited 
dephosphorylation of pY142 following DNA damage.  
 
However, the model proposed by Cook et al. suggests that siRNA inhibition of Eya 
leads to an increased conversion of pY142 to di-phosphorylated H2A.X, yet levels 
of pY142 did not decrease following IR and siRNA inhibition (Krishnan et al., 2009). 
Though this may be as a consequence of their anti-pY142 antibody cross-reacting 










4.3 Nuclear localisation of γH2A.X and di-γH2A.X 
4.3.1 Immunochemical findings 
The second hypothesis of Cook et al. is that Y142 is constitutively phosphorylated 
by WSTF at basal levels in undamaged cells, and gradually dephosphorylated by 
Eya following IR. Inhibition of Eya phosphatase thus leads to an increase in the 
level of di-γH2A.X, which they postulate to be an epigenetic mark specifically 
associated with apoptosis. This model was somewhat supported by Xiao et al. 
(Figure 1-5), in which pY142 decreased following IR, found by western blot 
analysis, though di-γH2A.X formation was not assessed. The decrease in pY142 
found could be a consequence of either pY142 conversion to Y142, or to di-
γH2A.X.  
 
To visualise the nuclear localisation patterns of γH2A.X and di-γH2A.X during the 
DDR, immunofluorescence was performed on 293T cells after treatment with 
Bleomycin. Cells were visualised in various stages of the DDR, ranging from a few 
small, distinct γH2A.X foci in early repair, to diffuse staining and the characteristic 
“apoptotic ring” in heavily damaged, unrepairable cells. In contrast to the 
hypothesis of Cook et al., di-γH2A.X foci were found to be localising with γH2A.X 
foci in early DNA repair, not just in apoptotic cells and increased at rates 
comparable vis-à-vis with γH2A.X. More specifically, the majority of γH2A.X foci 
appeared to be flanked by an adjacent di-γH2A.X focus and intriguingly, appeared 
to be interlocking in some cases. Apoptotic cells were found to have an 
interspersed signal of both γH2A.X and di-γH2A.X.  





4.3.2 New model of repair focus maturation 
As a result of the immunochemical studies, we propose a new model for the role of 
di-γH2A.X in the DDR (shown at Figure 4-3). We postulate that in support of 
previous findings, resting chromatin contains H2A.X that has basal levels of 
phosphorylated Y142 (Xiao et al., 2009). Following DSB induction, H2A.X is 
phosphorylated at S139 by ATM/ATR kinases, forming γH2A.X (Pilch et al., 2003) 
(Zhu et al., 2011); this allows recruitment of MDC1 (Stewart et al., 2003), which in 
turn recruits the MRN complex and in turn, additional ATM (You et al., 2005). ATM 
subsequently phosphorylates further S139 residues on adjacent H2A.X, allowing 
the spread of γH2A.X signalling in cis along the chromosome, moving outwards 
from the break site. This spreads the γH2A.X signal until which point it reaches an 
H2A.X that is already phosphorylated on Y142.  
 
Our new model suggests that at this stage, the phosphorylation of S139 on this 
H2A.X, already phosphorylated at Y142, thereby causes formation of di-γH2A.X. 
Since di-γH2A.X is unable to bind MDC1 (Cook et al., 2009; Campbell, Edwards 
and Glover, 2010), thus we propose that instead of being a determining factor of an 
epigenetic switch from DNA repair, to apoptosis, that this instead prevents the 
perpetual spreading of γH2A.X, allowing the retention and accumulation of DDR 
proteins at the site of DSBs. The lower affinity removal of pY142 by Eya 
phosphatase then converts di-γH2A.X to γH2A.X, allowing recruitment of more 
MDC1/MRN complex/ATM. Consequently, this enables phosphorylation of 
surrounding H2A.X and the γH2A.X repair focus to enlarge as it matures. 




















Figure 4-3 Proposed new model of the role of di-γH2A.X in the DDR 
A. Resting chromatin contains H2A.X that has basal levels of phosphorylated Y142 (pY142) B. At 
sites of DSBs, ATM/ATR kinase phosphorylates S139 of H2A.X, forming γH2A.X; this allows 
recruitment of MDC1, which in turn recruits the MRN complex and more ATM; ATM phosphorylates 
further S139 residues on adjacent H2A.X, allowing the spread of γH2A.X signalling in cis along the 
chromosome, moving outwards from the break site C. The γH2A.X signal spreads until it reaches 
an H2A.X that is already phosphorylated on Y142; phosphorylation of S139 on this H2A.X causes 
formation of di-γH2A.X. Di-γH2A.X blocks MDC1 recruitment and prevents the signal spreading 
further until Eya phosphatase converts the di-γH2A.X to γH2A.X by removing pY142 D. During 
repair focus maturation, the removal of pY142 by Eya phosphatase allows γH2A.X to recruit more 
MDC1; MDC1/MRN complex/ATM enables phosphorylation of surrounding H2A.X; this enables the 
γH2A.X repair focus to enlarge as it matures. 
 
 





Also interesting in this context are the findings of Xiao et al.: their western blot 
analysis showed that, in contrast to the increase in γH2A.X seen 1hr post-IR, which 
was sustained until 12hrs post-IR in wild-type cells, WSTF RNAi cells had initial 
formation of γH2A.X at 1hr post-IR, but that this was not maintained and had 
sharply decreased by 4hrs post-IR. This indicates that WSTF mediated 
phosphorylation of Y142 is necessary to maintain γH2A.X formation. Our model 
does not directly touch on this hypothesis, however our observation of adjacent 
localisation of mono- and di-γH2A.X domains may indicate that di-γH2A.X has 
some role in stabilising γH2A.X within chromatin. 
 
While a lot of research has thus far been directed towards the assembly of γH2A.X 
foci, very little is known about how they are disassembled after repair: the role of 
pY142 and di-γH2A.X in this will be interesting to explore, e.g. via work in WSTF-
null and Eya-null backgrounds. 
 
4.3.3 Apoptosis and caspase activated DNAse (CAD) 
Activation of DDR proteins occurs rapidly following IR induced DSBs, including 
auto- or trans-phosphorylation of ATM (pATM) at S1981  (Bakkenist and Kastan, 
2003; So, Davis and Chen, 2009) and autophosphorylation of DNA-PK (pDNA-PK) 
at T2609 (Chan et al., 2002). During the study of γH2A.X kinetics by Ding et al., 
they noted that in addition to correlation of pan-nuclear γH2A.X with TUNEL 
staining, that both pATM and pDNA-PKs foci formation followed a very similar 
pattern to that of γH2A.X foci, indicative of their role in the DDR.  





However, pan-staining of both pATM and pDNA-PK was found to follow a different 
kinetic pattern in that induction was slower than that of foci formation, peaking at 6-
hrs post-irradiation and decreasing to zero by 24-hrs. Inhibitors of ATM and DNA-
PK, p53 or pan-caspases all resulted in significantly less pan-nuclear γH2A.X, 
concluding that ATM and DNA-PK are therefore related to p53-dependent, 
caspase-3 dependent apoptosis induction, but are only activated at early stages. 
Solier et al. also found that the apoptotic ring colocalises with phosphorylated 
histone H2B (at serine-14), CHK2, ATM and DNA-PK (Solier et al., 2012)..   
 
Furthermore, caspase activated deoxyribonuclease (CAD) is normally sequestered 
in the cytoplasm as an inactive complex with its inhibitor ICAD, but is released by 
caspase-3 cleavage during apoptosis and is able to diffuse into the nucleus from 
outside-in, where it creates double strand breaks to initiate γH2A.X-dependent 
DNA degradation (Nagata et al., 1998; Rogakou et al., 2000; Lu et al., 2006). It is 
therefore proposed that the “apoptotic ring” is formed first at the nuclear periphery 
as a consequence of the influx of CAD and subsequent H2A.X phosphorylation, 
with successive spread inwards leading to pan-nuclear γH2A.X.  
 
Our immunofluorescence studies found evidence of both γH2A.X and di-γH2A.X in 
the apoptotic ring; whilst the mechanism of this has not been fully elucidated, it is 
plausible that upon apoptosis induction and influx of CAD, DSBs are formed that 
are phosphorylated at S139 on surrounding H2A.X by pDNA-PK/pATM; pre-
existing pY142, present at the nuclear periphery, may then be rapidly converted to 





di-γH2A.X through the phosphorylation of S139, resulting in the interspersed signal 
found. This rapid phosphorylation event thus may decrease the efficiency in which 
Eya phosphatase can dephosphorylate pY142, leading to a “blockade” in the 
recruitment of DDR proteins, and instead allow the recruitment of pro-apoptotic 
JNK-1, propagating the apoptotic response.  
 
4.3.4 Limitations of immunofluorescence and future directions 
4.3.4.1 3-D confocal imaging 
A clearer depiction of γH2A.X and di-γH2A.X nuclear localisation patterns would be 
achieved via super-resolution imaging and/or 3-D imaging of chromatin, providing a 
higher resolution understanding of the nuclear architectural microenvironment.  
 
4.3.4.2 Targeted systems for inducing DSBs 
In addition to a comparative study using alternative means of DNA damage 
induction to determine if this model is consistent in other DSB repair mechanisms 
(i.e. γ-irradiation, hypoxia treatment, topoisomerase inhibition), of interest would be 
the use of a more targeted system to allow for temporally and spatially controlled 
DSB induction at a defined number of genomic loci: by inducible endonuclease, for 
example. Followed by chromatin immunoprecipitation (ChIP), this would allow the 
study of specific protein-DNA interactions (Iacovoni et al., 2010; Aymard et al., 
2014). 
 







To recapitulate, whilst this project failed to find co-operativity between Bleomycin 
and Benzbromarone in cell proliferation assays, this was likely due to the 
limitations caused by using a concentration of Benzbromarone more than 4-fold 
less than that of the IC50; it is improbable that full inhibition of Eya phosphatase 
was achieved. Nevertheless, this concentration was still found to have some effect 
in apoptosis assays: using live-cell imaging, a more than 2-fold increase in 
apoptosis was achieved by co-administrating 25μM of Bleomycin with 8μM of 
Benzbromarone.  
 
Yet the most intriguing findings of this study have been found through 
immunochemical staining, whereby di-γH2A.X was found adjacent to, but not co-
localising with γH2A.X in DDR foci, appearing to “flank” the γH2A.X signal, as well 
as interlocking signals of both epigenetic states. In apoptotic cells, an interspersed 
signal, containing both γH2A.X and di-γH2A.X was found.  
 
This has led to a tentative new model for an additional role of di-γH2A.X, in that it 
acts in a mechanism in which to control DDR focus expansion, regulated by the 
Eya phosphotyrosine phosphatase. The proportion of pY142 in resting chromatin 
and level of Eya phosphatase may therefore act as a "gain control" for the intensity 
of the DNA damage response in different cell types. 
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Figure 6-1 The effect of Poly-D-Lysine on cell proliferation 
HEK293T cells seeded in untreated plates with no media change had the highest viability; in 
comparison, cell viability was lower in untreated plates when the media was changed, indicating 
loss of cells during media change through lack of adherence. Cells in Poly-D-Lysine treated plates 
with no media change had lower viability than untreated plates with no media change, indicating 
Poly-D-Lysine has some toxicity to 293T cells. However, no difference was seen between Poly-D-
Lysine treated cells with/without media change, indicating cells were not lost through media change. 
HEK293T cells were seeded in triplicate repeats in a 96-well plate, at either 2000, 1000 or 500 cells 
per well. 96-well plates were either untreated, or treated with Poly-D-Lysine and then washed twice 
with dH20 and once with 96% ethanol prior to seeding. After 24-hrs, media was changed on the 
plates indicated. Cells were incubated for 5-days before addition of MTT and absorbance read on a 











Figure 6-2 Co-operativity between Benzbromarone and a pulse treatment of Bleomycin, by 
cleaved caspase-3/7 detection 
Co-treatment of Bleomycin with 8μM of Benzbromarone increases apoptosis. HEK293T cells were 
seeded in quadruple repeats in treated 96-well plates, 2000 cells per well, with/without 8μM 
Benzbromarone. 24hrs later, cells were treated with a serial dilution of Bleomycin which was 
removed after 2-hrs and replaced with fresh media, with/without 8μM of Benzbromarone and 
incubated with Caspase 3/7 reagent in an IncuCyte Live-Cell Analysis System. Cell growth and 
apoptosis was monitored, capturing 4 images per well, every 2 hrs at 10x objective for 106-hrs. 
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